WO1993010677A1 - Specific eatable taste modifiers - Google Patents
Specific eatable taste modifiers Download PDFInfo
- Publication number
- WO1993010677A1 WO1993010677A1 PCT/US1992/010179 US9210179W WO9310677A1 WO 1993010677 A1 WO1993010677 A1 WO 1993010677A1 US 9210179 W US9210179 W US 9210179W WO 9310677 A1 WO9310677 A1 WO 9310677A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tastand
- physiologically acceptable
- acceptable salts
- acid
- group
- Prior art date
Links
- 235000019640 taste Nutrition 0.000 title claims abstract description 162
- 239000003607 modifier Substances 0.000 title description 5
- 150000001875 compounds Chemical class 0.000 claims abstract description 148
- 230000009967 tasteless effect Effects 0.000 claims abstract description 34
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical group [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 504
- 235000002639 sodium chloride Nutrition 0.000 claims description 492
- 150000003839 salts Chemical class 0.000 claims description 410
- 239000001103 potassium chloride Substances 0.000 claims description 253
- 235000011164 potassium chloride Nutrition 0.000 claims description 253
- 125000001424 substituent group Chemical group 0.000 claims description 190
- 239000000203 mixture Substances 0.000 claims description 187
- 235000019658 bitter taste Nutrition 0.000 claims description 167
- 238000000034 method Methods 0.000 claims description 150
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 143
- 229910052739 hydrogen Inorganic materials 0.000 claims description 117
- 229910052717 sulfur Inorganic materials 0.000 claims description 85
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 79
- 229910052760 oxygen Inorganic materials 0.000 claims description 74
- 239000011780 sodium chloride Substances 0.000 claims description 72
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 64
- 230000002829 reductive effect Effects 0.000 claims description 60
- 125000000217 alkyl group Chemical group 0.000 claims description 56
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 51
- 229910052799 carbon Inorganic materials 0.000 claims description 50
- 125000002877 alkyl aryl group Chemical group 0.000 claims description 48
- 229910052757 nitrogen Inorganic materials 0.000 claims description 48
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 45
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 claims description 44
- 229960003080 taurine Drugs 0.000 claims description 44
- 235000009508 confectionery Nutrition 0.000 claims description 42
- 235000003599 food sweetener Nutrition 0.000 claims description 41
- 239000003765 sweetening agent Substances 0.000 claims description 41
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 40
- YZQCXOFQZKCETR-UWVGGRQHSA-N Asp-Phe Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 YZQCXOFQZKCETR-UWVGGRQHSA-N 0.000 claims description 39
- 239000000463 material Substances 0.000 claims description 37
- 150000001413 amino acids Chemical group 0.000 claims description 35
- 229940000635 beta-alanine Drugs 0.000 claims description 35
- 235000019643 salty taste Nutrition 0.000 claims description 35
- 125000003118 aryl group Chemical group 0.000 claims description 30
- 229910052796 boron Inorganic materials 0.000 claims description 30
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 claims description 30
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 29
- 239000011593 sulfur Substances 0.000 claims description 29
- UIAFKZKHHVMJGS-UHFFFAOYSA-N 2,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1O UIAFKZKHHVMJGS-UHFFFAOYSA-N 0.000 claims description 28
- 229910052698 phosphorus Inorganic materials 0.000 claims description 28
- 239000000126 substance Substances 0.000 claims description 28
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 27
- 239000001257 hydrogen Substances 0.000 claims description 27
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 27
- 125000004122 cyclic group Chemical group 0.000 claims description 25
- 108010011485 Aspartame Proteins 0.000 claims description 24
- 239000000605 aspartame Substances 0.000 claims description 24
- 235000010357 aspartame Nutrition 0.000 claims description 24
- 229960003438 aspartame Drugs 0.000 claims description 24
- 229940024606 amino acid Drugs 0.000 claims description 23
- 235000001014 amino acid Nutrition 0.000 claims description 23
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 23
- 239000001301 oxygen Substances 0.000 claims description 23
- MIEKOFWWHVOKQX-UHFFFAOYSA-N (S)-2-(4-Methoxyphenoxy)propanoic acid Chemical compound COC1=CC=C(OC(C)C(O)=O)C=C1 MIEKOFWWHVOKQX-UHFFFAOYSA-N 0.000 claims description 22
- 235000019204 saccharin Nutrition 0.000 claims description 22
- 229940081974 saccharin Drugs 0.000 claims description 22
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 claims description 22
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 21
- 230000002209 hydrophobic effect Effects 0.000 claims description 20
- 230000003993 interaction Effects 0.000 claims description 20
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 20
- 238000006467 substitution reaction Methods 0.000 claims description 19
- 239000004094 surface-active agent Substances 0.000 claims description 19
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 18
- -1 aralkyI Chemical group 0.000 claims description 17
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 claims description 16
- 239000002253 acid Substances 0.000 claims description 16
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 15
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 15
- 239000000619 acesulfame-K Substances 0.000 claims description 15
- 150000001768 cations Chemical class 0.000 claims description 15
- 125000003107 substituted aryl group Chemical group 0.000 claims description 15
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims description 15
- 229940114055 beta-resorcylic acid Drugs 0.000 claims description 14
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 13
- GLDQAMYCGOIJDV-UHFFFAOYSA-N 2,3-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC(O)=C1O GLDQAMYCGOIJDV-UHFFFAOYSA-N 0.000 claims description 12
- IBHWREHFNDMRPR-UHFFFAOYSA-N 2,4,6-Trihydroxybenzoic acid Chemical compound OC(=O)C1=C(O)C=C(O)C=C1O IBHWREHFNDMRPR-UHFFFAOYSA-N 0.000 claims description 12
- 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 claims description 12
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims description 12
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 12
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 claims description 12
- 229910052783 alkali metal Inorganic materials 0.000 claims description 12
- 150000001340 alkali metals Chemical class 0.000 claims description 12
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 12
- 150000001342 alkaline earth metals Chemical class 0.000 claims description 12
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- CDAISMWEOUEBRE-UHFFFAOYSA-N inositol Chemical compound OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 12
- 235000013615 non-nutritive sweetener Nutrition 0.000 claims description 12
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 claims description 12
- 235000013305 food Nutrition 0.000 claims description 11
- 239000008123 high-intensity sweetener Substances 0.000 claims description 11
- AKEUNCKRJATALU-UHFFFAOYSA-N 2,6-dihydroxybenzoic acid Chemical compound OC(=O)C1=C(O)C=CC=C1O AKEUNCKRJATALU-UHFFFAOYSA-N 0.000 claims description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 10
- KDGAYJIGGCDHPH-UHFFFAOYSA-N L-beta-aspartyl-L-phenylalanine Chemical compound OC(=O)C(N)CC(=O)NC(C(O)=O)CC1=CC=CC=C1 KDGAYJIGGCDHPH-UHFFFAOYSA-N 0.000 claims description 10
- 108091005708 gustatory receptors Proteins 0.000 claims description 10
- LCPDWSOZIOUXRV-UHFFFAOYSA-N phenoxyacetic acid Chemical compound OC(=O)COC1=CC=CC=C1 LCPDWSOZIOUXRV-UHFFFAOYSA-N 0.000 claims description 10
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims description 9
- FRYULLIZUDQONW-IMJSIDKUSA-N Asp-Asp Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(O)=O FRYULLIZUDQONW-IMJSIDKUSA-N 0.000 claims description 9
- CKLJMWTZIZZHCS-UWTATZPHSA-N D-aspartic acid Chemical compound OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 claims description 9
- 150000004000 hexols Chemical class 0.000 claims description 9
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 9
- 235000019260 propionic acid Nutrition 0.000 claims description 9
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims description 9
- WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 claims description 8
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 claims description 8
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 claims description 8
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 8
- 229940029575 guanosine Drugs 0.000 claims description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 8
- 229950000244 sulfanilic acid Drugs 0.000 claims description 8
- GPNNOCMCNFXRAO-UHFFFAOYSA-N 2-aminoterephthalic acid Chemical compound NC1=CC(C(O)=O)=CC=C1C(O)=O GPNNOCMCNFXRAO-UHFFFAOYSA-N 0.000 claims description 7
- NALWOULWGHTVDA-UWVGGRQHSA-N Asp-Tyr Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 NALWOULWGHTVDA-UWVGGRQHSA-N 0.000 claims description 7
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 claims description 7
- WHUUTDBJXJRKMK-GSVOUGTGSA-N D-glutamic acid Chemical compound OC(=O)[C@H](N)CCC(O)=O WHUUTDBJXJRKMK-GSVOUGTGSA-N 0.000 claims description 7
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 7
- 235000019270 ammonium chloride Nutrition 0.000 claims description 7
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical group OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 7
- 235000013361 beverage Nutrition 0.000 claims description 7
- 150000001721 carbon Chemical class 0.000 claims description 7
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 7
- 238000009472 formulation Methods 0.000 claims description 7
- 239000011574 phosphorus Substances 0.000 claims description 7
- 235000014347 soups Nutrition 0.000 claims description 7
- QQVDJLLNRSOCEL-UHFFFAOYSA-N (2-aminoethyl)phosphonic acid Chemical compound [NH3+]CCP(O)([O-])=O QQVDJLLNRSOCEL-UHFFFAOYSA-N 0.000 claims description 6
- 229940082044 2,3-dihydroxybenzoic acid Drugs 0.000 claims description 6
- FSQDURCMBCGCIK-UHFFFAOYSA-N 2-(2,4-dihydroxyphenyl)acetic acid Chemical compound OC(=O)CC1=CC=C(O)C=C1O FSQDURCMBCGCIK-UHFFFAOYSA-N 0.000 claims description 6
- ZCYXGVJUZBKJAI-UHFFFAOYSA-N 3,4,5-trimethoxydihydrocinnamic acid Chemical compound COC1=CC(CCC(O)=O)=CC(OC)=C1OC ZCYXGVJUZBKJAI-UHFFFAOYSA-N 0.000 claims description 6
- UYEMGAFJOZZIFP-UHFFFAOYSA-N 3,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC(O)=C1 UYEMGAFJOZZIFP-UHFFFAOYSA-N 0.000 claims description 6
- LHHKQWQTBCTDQM-UHFFFAOYSA-N 3-(3,4-dimethoxyphenyl)propanoic acid Chemical compound COC1=CC=C(CCC(O)=O)C=C1OC LHHKQWQTBCTDQM-UHFFFAOYSA-N 0.000 claims description 6
- LEGPZHPSIPPYIO-UHFFFAOYSA-N 3-Methoxyphenylacetic acid Chemical compound COC1=CC=CC(CC(O)=O)=C1 LEGPZHPSIPPYIO-UHFFFAOYSA-N 0.000 claims description 6
- LBKFGYZQBSGRHY-UHFFFAOYSA-N 3-hydroxy-4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1O LBKFGYZQBSGRHY-UHFFFAOYSA-N 0.000 claims description 6
- OMTDIBZSUZNVJK-UHFFFAOYSA-N 4-(4-methoxyphenyl)-4-oxobutanoic acid Chemical compound COC1=CC=C(C(=O)CCC(O)=O)C=C1 OMTDIBZSUZNVJK-UHFFFAOYSA-N 0.000 claims description 6
- NFPYJDZQOKCYIE-UHFFFAOYSA-N 4-amino-3-hydroxybenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1O NFPYJDZQOKCYIE-UHFFFAOYSA-N 0.000 claims description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 6
- 229930010555 Inosine Natural products 0.000 claims description 6
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 claims description 6
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 6
- KFKWRHQBZQICHA-STQMWFEESA-N Leu-Phe Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 KFKWRHQBZQICHA-STQMWFEESA-N 0.000 claims description 6
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 claims description 6
- BJXXCOMGRRCAGN-CLFAGFIQSA-N [2,2-bis(hydroxymethyl)-3-[(z)-octadec-9-enoyl]oxypropyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(CO)(CO)COC(=O)CCCCCCC\C=C/CCCCCCCC BJXXCOMGRRCAGN-CLFAGFIQSA-N 0.000 claims description 6
- 150000007513 acids Chemical class 0.000 claims description 6
- 150000001720 carbohydrates Chemical class 0.000 claims description 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 6
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 claims description 6
- 229960003786 inosine Drugs 0.000 claims description 6
- BTNMPGBKDVTSJY-UHFFFAOYSA-N keto-phenylpyruvic acid Chemical compound OC(=O)C(=O)CC1=CC=CC=C1 BTNMPGBKDVTSJY-UHFFFAOYSA-N 0.000 claims description 6
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 claims description 6
- PXQPEWDEAKTCGB-UHFFFAOYSA-N orotic acid Chemical compound OC(=O)C1=CC(=O)NC(=O)N1 PXQPEWDEAKTCGB-UHFFFAOYSA-N 0.000 claims description 6
- IMPKVMRTXBRHRB-UHFFFAOYSA-N scyllo-Quercitol Natural products OC1CC(O)C(O)C(O)C1O IMPKVMRTXBRHRB-UHFFFAOYSA-N 0.000 claims description 6
- DSHDHKLHCMKZCS-ZETCQYMHSA-N 2-[[(2s)-2-amino-3-carboxypropanoyl]amino]benzoic acid Chemical compound OC(=O)C[C@H](N)C(=O)NC1=CC=CC=C1C(O)=O DSHDHKLHCMKZCS-ZETCQYMHSA-N 0.000 claims description 5
- YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 claims description 5
- GPAABQWHCYKKEG-LURJTMIESA-N 3-[[(2s)-2,5-diaminopentanoyl]amino]propanoic acid Chemical compound NCCC[C@H](N)C(=O)NCCC(O)=O GPAABQWHCYKKEG-LURJTMIESA-N 0.000 claims description 5
- YBPGDUXTZMTLGI-ZETCQYMHSA-N 3-[[(2s)-2,6-diaminohexanoyl]amino]propanoic acid Chemical compound NCCCC[C@H](N)C(=O)NCCC(O)=O YBPGDUXTZMTLGI-ZETCQYMHSA-N 0.000 claims description 5
- QBVDNGPBNCEDPJ-WJXVXWFNSA-N 3-aminopropanoic acid;(2s)-2,5-diaminopentanoic acid;dihydrochloride Chemical compound Cl.Cl.NCCC(O)=O.NCCC[C@H](N)C(O)=O QBVDNGPBNCEDPJ-WJXVXWFNSA-N 0.000 claims description 5
- CSPCBKHSMMVMKX-QMMMGPOBSA-N 4-[[(2s)-2-amino-3-carboxypropanoyl]amino]benzoic acid Chemical compound OC(=O)C[C@H](N)C(=O)NC1=CC=C(C(O)=O)C=C1 CSPCBKHSMMVMKX-QMMMGPOBSA-N 0.000 claims description 5
- 229930182847 D-glutamic acid Natural products 0.000 claims description 5
- YGCFIWIQZPHFLU-UHFFFAOYSA-N acesulfame Chemical compound CC1=CC(=O)NS(=O)(=O)O1 YGCFIWIQZPHFLU-UHFFFAOYSA-N 0.000 claims description 5
- 150000001408 amides Chemical class 0.000 claims description 5
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 5
- 239000002738 chelating agent Substances 0.000 claims description 5
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 claims description 5
- 229930014626 natural product Natural products 0.000 claims description 5
- 235000013599 spices Nutrition 0.000 claims description 5
- DCTLYFZHFGENCW-UUOKFMHZSA-N 5'-xanthylic acid Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(NC(=O)NC2=O)=C2N=C1 DCTLYFZHFGENCW-UUOKFMHZSA-N 0.000 claims description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims description 4
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 4
- JINBYESILADKFW-UHFFFAOYSA-N aminomalonic acid Chemical compound OC(=O)C(N)C(O)=O JINBYESILADKFW-UHFFFAOYSA-N 0.000 claims description 4
- 230000000295 complement effect Effects 0.000 claims description 4
- UFIVEPVSAGBUSI-UHFFFAOYSA-N dihydroorotic acid Chemical compound OC(=O)C1CC(=O)NC(=O)N1 UFIVEPVSAGBUSI-UHFFFAOYSA-N 0.000 claims description 4
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 4
- 229960000367 inositol Drugs 0.000 claims description 4
- 235000014655 lactic acid Nutrition 0.000 claims description 4
- 239000004310 lactic acid Substances 0.000 claims description 4
- 229920001308 poly(aminoacid) Polymers 0.000 claims description 4
- 235000002906 tartaric acid Nutrition 0.000 claims description 4
- 239000011975 tartaric acid Substances 0.000 claims description 4
- 239000000892 thaumatin Substances 0.000 claims description 4
- 235000010436 thaumatin Nutrition 0.000 claims description 4
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 3
- IMPKVMRTXBRHRB-MBMOQRBOSA-N (+)-quercitol Chemical compound O[C@@H]1C[C@@H](O)[C@H](O)C(O)[C@H]1O IMPKVMRTXBRHRB-MBMOQRBOSA-N 0.000 claims description 3
- PWSKXRKZLJHEKE-VFUOTHLCSA-N (1r,2r,3r,4r,5r)-3-amino-6,8-dioxabicyclo[3.2.1]octane-2,4-diol Chemical compound O1[C@@]2([H])OC[C@]1([H])[C@H](O)[C@@H](N)[C@H]2O PWSKXRKZLJHEKE-VFUOTHLCSA-N 0.000 claims description 3
- TUTSXAYHDSAHAQ-UIAUGNHASA-N (1r,2s,3r,4s,5r)-3-(dimethylamino)-6,8-dioxabicyclo[3.2.1]octane-2,4-diol Chemical compound O1[C@@]2([H])OC[C@]1([H])[C@@H](O)[C@@H](N(C)C)[C@@H]2O TUTSXAYHDSAHAQ-UIAUGNHASA-N 0.000 claims description 3
- TUTSXAYHDSAHAQ-OZRXBMAMSA-N (1r,2s,3s,4r,5r)-3-(dimethylamino)-6,8-dioxabicyclo[3.2.1]octane-2,4-diol Chemical compound O1[C@@]2([H])OC[C@]1([H])[C@@H](O)[C@H](N(C)C)[C@H]2O TUTSXAYHDSAHAQ-OZRXBMAMSA-N 0.000 claims description 3
- IMPKVMRTXBRHRB-RSVSWTKNSA-N (1r,2s,4r,5r)-cyclohexane-1,2,3,4,5-pentol Chemical compound O[C@@H]1C[C@@H](O)[C@@H](O)C(O)[C@H]1O IMPKVMRTXBRHRB-RSVSWTKNSA-N 0.000 claims description 3
- LYLSUYCOHWVOFS-OVHBTUCOSA-N (1r,3s,4r,5s,8r)-3-methoxy-2,6-dioxabicyclo[3.2.1]octane-4,8-diol Chemical compound O[C@H]1[C@@H](OC)O[C@@H]2CO[C@H]1[C@@H]2O LYLSUYCOHWVOFS-OVHBTUCOSA-N 0.000 claims description 3
- HLEDYOCFNKRBQS-WWALYXLFSA-N (2S)-2-amino-3-hydroxy-N-[(2R)-1-oxo-1-[(1,2,2,3-tetramethylcyclopentyl)amino]propan-2-yl]propanamide Chemical compound CC1CCC(C1(C)C)(C)NC(=O)[C@@H](C)NC(=O)[C@H](CO)N HLEDYOCFNKRBQS-WWALYXLFSA-N 0.000 claims description 3
- LYZONRZEOLEFOU-NTXUUIFSSA-N (2S)-2-amino-4-methyl-N-[(2R)-1-oxo-1-[(1,2,2,3-tetramethylcyclopentyl)amino]propan-2-yl]pentanamide Chemical compound CC1CCC(C1(C)C)(C)NC(=O)[C@@H](C)NC(=O)[C@H](CC(C)C)N LYZONRZEOLEFOU-NTXUUIFSSA-N 0.000 claims description 3
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 claims description 3
- OETRAPPMILRBSS-YQXRAVKXSA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-4,6-dimethoxyoxane-3,5-diol Chemical compound CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC)[C@H]1O OETRAPPMILRBSS-YQXRAVKXSA-N 0.000 claims description 3
- MRGPKZIDNGFPIU-KVTDHHQDSA-N (2r,3r,4s,5s)-6-chlorohexane-1,2,3,4,5-pentol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CCl MRGPKZIDNGFPIU-KVTDHHQDSA-N 0.000 claims description 3
- ZBDGHWFPLXXWRD-ARQDHWQXSA-N (2r,3s,4r,5r)-2-methoxyoxane-3,4,5-triol Chemical compound CO[C@@H]1OC[C@@H](O)[C@@H](O)[C@@H]1O ZBDGHWFPLXXWRD-ARQDHWQXSA-N 0.000 claims description 3
- ZHVNVPHMOCWHHO-DPYQTVNSSA-N (2r,3s,4r,5s)-6-chloro-2,3,4,5-tetrahydroxyhexanal Chemical compound ClC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O ZHVNVPHMOCWHHO-DPYQTVNSSA-N 0.000 claims description 3
- KDRHBILXXHMIFJ-CBQIKETKSA-N (2r,3s,4s,5r,6s)-2-(hydroxymethyl)-5,6-dimethoxyoxane-3,4-diol Chemical compound CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1OC KDRHBILXXHMIFJ-CBQIKETKSA-N 0.000 claims description 3
- TTXGMVXSNBMYNY-YTLHQDLWSA-N (2r,3s,5s,6s)-2-(hydroxymethyl)-6-methoxyoxane-3,5-diol Chemical compound CO[C@H]1O[C@H](CO)[C@@H](O)C[C@@H]1O TTXGMVXSNBMYNY-YTLHQDLWSA-N 0.000 claims description 3
- FJFRHMFVCLTWOW-CBQIKETKSA-N (2s,3r,4s,5s,6r)-2-methoxy-6-(methoxymethyl)oxane-3,4,5-triol Chemical compound COC[C@H]1O[C@H](OC)[C@H](O)[C@@H](O)[C@@H]1O FJFRHMFVCLTWOW-CBQIKETKSA-N 0.000 claims description 3
- MYGVPKMVGSXPCQ-UHFFFAOYSA-N (3-amino-4-hydroxy-4-oxobutyl)-dimethylsulfanium chloride Chemical compound [Cl-].C[S+](C)CCC(N)C(O)=O MYGVPKMVGSXPCQ-UHFFFAOYSA-N 0.000 claims description 3
- DWBZEJHQQIURML-IUYQGCFVSA-N (3s)-3-amino-4-[[(1r)-1-carboxy-2-hydroxyethyl]amino]-4-oxobutanoic acid Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](CO)C(O)=O DWBZEJHQQIURML-IUYQGCFVSA-N 0.000 claims description 3
- DVUFTQLHHHJEMK-DMTCNVIQSA-N (3s)-3-amino-4-[[(1r)-1-carboxyethyl]amino]-4-oxobutanoic acid Chemical compound OC(=O)[C@@H](C)NC(=O)[C@@H](N)CC(O)=O DVUFTQLHHHJEMK-DMTCNVIQSA-N 0.000 claims description 3
- KUEMUSIPJOWTBX-WDEREUQCSA-N (3s)-3-amino-4-[[(2r)-3-(4-hydroxyphenyl)-1-methoxy-1-oxopropan-2-yl]amino]-4-oxobutanoic acid Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](C(=O)OC)CC1=CC=C(O)C=C1 KUEMUSIPJOWTBX-WDEREUQCSA-N 0.000 claims description 3
- QPUZSCXGJMEHBV-QMMMGPOBSA-N (3s)-3-amino-4-oxo-4-(4-sulfoanilino)butanoic acid Chemical compound OC(=O)C[C@H](N)C(=O)NC1=CC=C(S(O)(=O)=O)C=C1 QPUZSCXGJMEHBV-QMMMGPOBSA-N 0.000 claims description 3
- FDHNLHLOJLLXDH-JIYHLSBYSA-N (e)-3-(3-hydroxy-4-methoxyphenyl)-1-[2-hydroxy-6-methoxy-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxyphenyl]prop-2-en-1-one Chemical compound C1=C(O)C(OC)=CC=C1\C=C\C(=O)C(C(=C1)OC)=C(O)C=C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 FDHNLHLOJLLXDH-JIYHLSBYSA-N 0.000 claims description 3
- YJJBSMOKINSQQF-UHFFFAOYSA-N 1,2-dimethyl-4-nitroimidazole Chemical compound CC1=NC([N+]([O-])=O)=CN1C YJJBSMOKINSQQF-UHFFFAOYSA-N 0.000 claims description 3
- NVKQKAZYUPPRJX-UHFFFAOYSA-N 1,3,5-tribromo-2-(2,5-dibromophenyl)benzene Chemical compound BrC1=CC=C(Br)C(C=2C(=CC(Br)=CC=2Br)Br)=C1 NVKQKAZYUPPRJX-UHFFFAOYSA-N 0.000 claims description 3
- BVRNERFWPQRVJB-UHFFFAOYSA-N 2-(2,3-dihydro-1,4-benzodioxin-6-yl)acetic acid Chemical compound O1CCOC2=CC(CC(=O)O)=CC=C21 BVRNERFWPQRVJB-UHFFFAOYSA-N 0.000 claims description 3
- BNMTZMOQBMUUHJ-UHFFFAOYSA-N 2-(2,4-dihydroxyphenoxy)acetic acid Chemical compound OC(=O)COC1=CC=C(O)C=C1O BNMTZMOQBMUUHJ-UHFFFAOYSA-N 0.000 claims description 3
- SEVZMEUCICLUSK-UHFFFAOYSA-N 2-(2,4-dihydroxyphenoxy)propanoic acid Chemical compound OC(=O)C(C)OC1=CC=C(O)C=C1O SEVZMEUCICLUSK-UHFFFAOYSA-N 0.000 claims description 3
- NYYUKTMZQJKAHT-UHFFFAOYSA-N 2-(2,4-dihydroxyphenyl)propanoic acid Chemical compound OC(=O)C(C)C1=CC=C(O)C=C1O NYYUKTMZQJKAHT-UHFFFAOYSA-N 0.000 claims description 3
- IVEWTCACRDEAOB-UHFFFAOYSA-N 2-(2-methoxyphenyl)acetic acid Chemical compound COC1=CC=CC=C1CC(O)=O IVEWTCACRDEAOB-UHFFFAOYSA-N 0.000 claims description 3
- VNQCEHOLSJDEMQ-UHFFFAOYSA-N 2-(4-ethoxyphenoxy)propanoic acid Chemical compound CCOC1=CC=C(OC(C)C(O)=O)C=C1 VNQCEHOLSJDEMQ-UHFFFAOYSA-N 0.000 claims description 3
- BHFSBJHPPFJCOS-UHFFFAOYSA-N 2-(4-methoxyphenoxy)acetic acid Chemical compound COC1=CC=C(OCC(O)=O)C=C1 BHFSBJHPPFJCOS-UHFFFAOYSA-N 0.000 claims description 3
- KBDLTYNZHQRMQC-UHFFFAOYSA-N 2-(4-methoxyphenyl)propanoic acid Chemical compound COC1=CC=C(C(C)C(O)=O)C=C1 KBDLTYNZHQRMQC-UHFFFAOYSA-N 0.000 claims description 3
- GXXXUZIRGXYDFP-UHFFFAOYSA-N 2-(4-methylphenyl)acetic acid Chemical compound CC1=CC=C(CC(O)=O)C=C1 GXXXUZIRGXYDFP-UHFFFAOYSA-N 0.000 claims description 3
- HNORVZDAANCHAY-UHFFFAOYSA-N 2-[4-(trifluoromethyl)phenyl]acetic acid Chemical compound OC(=O)CC1=CC=C(C(F)(F)F)C=C1 HNORVZDAANCHAY-UHFFFAOYSA-N 0.000 claims description 3
- JALOHEZOHSEEMS-LURJTMIESA-N 2-[[(2s)-2,5-diaminopentanoyl]amino]ethanesulfonic acid Chemical compound NCCC[C@H](N)C(=O)NCCS(O)(=O)=O JALOHEZOHSEEMS-LURJTMIESA-N 0.000 claims description 3
- GOYZLPIPTDNVIG-ZETCQYMHSA-N 2-[[(2s)-2,6-diaminohexanoyl]amino]ethanesulfonic acid Chemical compound NCCCC[C@H](N)C(=O)NCCS(O)(=O)=O GOYZLPIPTDNVIG-ZETCQYMHSA-N 0.000 claims description 3
- ABOWENPAEUTPIO-LURJTMIESA-N 2-[[(2s)-2-amino-4-methylsulfanylbutanoyl]amino]ethanesulfonic acid Chemical compound CSCC[C@H](N)C(=O)NCCS(O)(=O)=O ABOWENPAEUTPIO-LURJTMIESA-N 0.000 claims description 3
- 239000001903 2-oxo-3-phenylpropanoic acid Substances 0.000 claims description 3
- XMOVIHPXNXYUQE-UHFFFAOYSA-N 3-(2,3,4-trimethoxyphenoxy)propanoic acid Chemical compound COC1=CC=C(OCCC(O)=O)C(OC)=C1OC XMOVIHPXNXYUQE-UHFFFAOYSA-N 0.000 claims description 3
- XSZSNLOPIWWFHS-UHFFFAOYSA-N 3-(2-methoxyphenyl)propanoic acid Chemical compound COC1=CC=CC=C1CCC(O)=O XSZSNLOPIWWFHS-UHFFFAOYSA-N 0.000 claims description 3
- AJDCBYMKYSZSLT-UHFFFAOYSA-N 3-(3,4-dimethoxyphenoxy)propanoic acid Chemical compound COC1=CC=C(OCCC(O)=O)C=C1OC AJDCBYMKYSZSLT-UHFFFAOYSA-N 0.000 claims description 3
- GNPISAHACGIXLZ-UHFFFAOYSA-N 3-(4-methylphenoxy)propanoic acid Chemical compound CC1=CC=C(OCCC(O)=O)C=C1 GNPISAHACGIXLZ-UHFFFAOYSA-N 0.000 claims description 3
- JYLUOTCHTVZCDL-UHFFFAOYSA-N 4-(2,4-dimethylphenyl)-4-oxobutanoic acid Chemical compound CC1=CC=C(C(=O)CCC(O)=O)C(C)=C1 JYLUOTCHTVZCDL-UHFFFAOYSA-N 0.000 claims description 3
- BUAYFJKMVBIPKA-UHFFFAOYSA-N 4-(3,4-dimethoxyphenyl)-4-oxobutanoic acid Chemical compound COC1=CC=C(C(=O)CCC(O)=O)C=C1OC BUAYFJKMVBIPKA-UHFFFAOYSA-N 0.000 claims description 3
- GEJYPKVVJBZIEE-UHFFFAOYSA-N 4-(3-carboxypropanoyl)benzoic acid Chemical compound OC(=O)CCC(=O)C1=CC=C(C(O)=O)C=C1 GEJYPKVVJBZIEE-UHFFFAOYSA-N 0.000 claims description 3
- VCJJBGLFBFVFLR-UHFFFAOYSA-N 4-(4-ethoxy-3-ethylphenyl)-4-oxobutanoic acid Chemical compound CCOC1=CC=C(C(=O)CCC(O)=O)C=C1CC VCJJBGLFBFVFLR-UHFFFAOYSA-N 0.000 claims description 3
- DSOGEBHLBXPYTC-UHFFFAOYSA-N 4-(4-ethoxy-3-methylphenyl)-4-oxobutanoic acid Chemical compound CCOC1=CC=C(C(=O)CCC(O)=O)C=C1C DSOGEBHLBXPYTC-UHFFFAOYSA-N 0.000 claims description 3
- MWTJDUAZKXENEH-UHFFFAOYSA-N 4-(4-ethyl-2-methylphenyl)-4-oxobutanoic acid Chemical compound CCC1=CC=C(C(=O)CCC(O)=O)C(C)=C1 MWTJDUAZKXENEH-UHFFFAOYSA-N 0.000 claims description 3
- RVDWUHPNGCQYRK-UHFFFAOYSA-N 4-(4-hydroxy-3-methylphenyl)-4-oxobutanoic acid Chemical compound CC1=CC(C(=O)CCC(O)=O)=CC=C1O RVDWUHPNGCQYRK-UHFFFAOYSA-N 0.000 claims description 3
- QKDLXQWEBIYZSS-UHFFFAOYSA-N 4-(4-hydroxyphenyl)-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)C1=CC=C(O)C=C1 QKDLXQWEBIYZSS-UHFFFAOYSA-N 0.000 claims description 3
- NYKZHPAJYHMOLD-UHFFFAOYSA-N 4-(4-methoxyphenyl)-2-methyl-4-oxobutanoic acid Chemical compound COC1=CC=C(C(=O)CC(C)C(O)=O)C=C1 NYKZHPAJYHMOLD-UHFFFAOYSA-N 0.000 claims description 3
- HLIAREKHQFODGA-UHFFFAOYSA-N 4-(4-methoxyphenyl)-3-methyl-4-oxobutanoic acid Chemical compound COC1=CC=C(C(=O)C(C)CC(O)=O)C=C1 HLIAREKHQFODGA-UHFFFAOYSA-N 0.000 claims description 3
- LZHMNCJMXQKSBY-UHFFFAOYSA-N 4-(4-methoxyphenyl)butanoic acid Chemical compound COC1=CC=C(CCCC(O)=O)C=C1 LZHMNCJMXQKSBY-UHFFFAOYSA-N 0.000 claims description 3
- QWOIQKXIBFKZKN-UHFFFAOYSA-N 4-oxo-4-(2,4,6-trimethylphenyl)butanoic acid Chemical compound CC1=CC(C)=C(C(=O)CCC(O)=O)C(C)=C1 QWOIQKXIBFKZKN-UHFFFAOYSA-N 0.000 claims description 3
- ZHVNVPHMOCWHHO-UHFFFAOYSA-N 6-chloro-2,3,4,5-tetrahydroxyhexanal Chemical compound ClCC(O)C(O)C(O)C(O)C=O ZHVNVPHMOCWHHO-UHFFFAOYSA-N 0.000 claims description 3
- DWBZEJHQQIURML-IMJSIDKUSA-N Asp-Ser Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(O)=O DWBZEJHQQIURML-IMJSIDKUSA-N 0.000 claims description 3
- NTQDELBZOMWXRS-IWGUZYHVSA-N Asp-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(O)=O NTQDELBZOMWXRS-IWGUZYHVSA-N 0.000 claims description 3
- VCCNKWWXYVWTLT-DGQSHKQTSA-N Diosmetin 7-neohesperidoside Natural products O([C@@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1Oc1cc(O)c2C(=O)C=C(c3cc(O)c(OC)cc3)Oc2c1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](C)O1 VCCNKWWXYVWTLT-DGQSHKQTSA-N 0.000 claims description 3
- XMBSYZWANAQXEV-QWRGUYRKSA-N Glu-Phe Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-QWRGUYRKSA-N 0.000 claims description 3
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 claims description 3
- DJOWTWWHMWQATC-KYHIUUMWSA-N Karpoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1(O)C(C)(C)CC(O)CC1(C)O)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C DJOWTWWHMWQATC-KYHIUUMWSA-N 0.000 claims description 3
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 claims description 3
- HGCNKOLVKRAVHD-RYUDHWBXSA-N Met-Phe Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 HGCNKOLVKRAVHD-RYUDHWBXSA-N 0.000 claims description 3
- ANKIAKMHIAGBNN-LURJTMIESA-N Met-beta-Ala Chemical compound CSCC[C@H](N)C(=O)NCCC(O)=O ANKIAKMHIAGBNN-LURJTMIESA-N 0.000 claims description 3
- 101710084933 Miraculin Proteins 0.000 claims description 3
- RINSJDWDXSWUOK-UHFFFAOYSA-N OC(=O)C1=CC=C(O)C(O)=C1.OC(=O)C1=CC=C(O)C(O)=C1 Chemical compound OC(=O)C1=CC=C(O)C(O)=C1.OC(=O)C1=CC=C(O)C(O)=C1 RINSJDWDXSWUOK-UHFFFAOYSA-N 0.000 claims description 3
- PPQRSMGDOHLTBE-UWVGGRQHSA-N Ser-Phe Chemical compound OC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 PPQRSMGDOHLTBE-UWVGGRQHSA-N 0.000 claims description 3
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 3
- 239000004473 Threonine Substances 0.000 claims description 3
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 claims description 3
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 claims description 3
- CCRMHSSCYUGPJJ-YGUHCRNKSA-N [C@H]1(C[C@H](O)[C@H](O)[C@H](O1)CO)[C@@]1(O)C[C@H](O)[C@H](O)[C@H](O1)CO Chemical compound [C@H]1(C[C@H](O)[C@H](O)[C@H](O1)CO)[C@@]1(O)C[C@H](O)[C@H](O)[C@H](O1)CO CCRMHSSCYUGPJJ-YGUHCRNKSA-N 0.000 claims description 3
- MRAJPHXZVBYJEU-WEAWNAATSA-N [C@H]1([C@H](O)C[C@H](O)[C@H](O1)CO)[C@@]1(O)[C@H](O)C[C@H](O)[C@H](O1)CO Chemical compound [C@H]1([C@H](O)C[C@H](O)[C@H](O1)CO)[C@@]1(O)[C@H](O)C[C@H](O)[C@H](O1)CO MRAJPHXZVBYJEU-WEAWNAATSA-N 0.000 claims description 3
- DEDGUGJNLNLJSR-UHFFFAOYSA-N alpha-hydroxycinnamic acid Natural products OC(=O)C(O)=CC1=CC=CC=C1 DEDGUGJNLNLJSR-UHFFFAOYSA-N 0.000 claims description 3
- 150000008064 anhydrides Chemical class 0.000 claims description 3
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 claims description 3
- 239000004067 bulking agent Substances 0.000 claims description 3
- 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 claims description 3
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 claims description 3
- 150000003950 cyclic amides Chemical class 0.000 claims description 3
- 229940068840 d-biotin Drugs 0.000 claims description 3
- 230000007423 decrease Effects 0.000 claims description 3
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical class C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 claims description 3
- ARPJZLLWCWXWJQ-UHFFFAOYSA-N dihydrogen phosphate;ethylazanium Chemical compound CCN.OP(O)(O)=O ARPJZLLWCWXWJQ-UHFFFAOYSA-N 0.000 claims description 3
- 229940074391 gallic acid Drugs 0.000 claims description 3
- 235000004515 gallic acid Nutrition 0.000 claims description 3
- 229940025878 hesperidin Drugs 0.000 claims description 3
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 claims description 3
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 claims description 3
- 229940076640 hesperidin methylchalcone Drugs 0.000 claims description 3
- 239000003112 inhibitor Substances 0.000 claims description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 3
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims description 3
- TWDDETOCLAWUAT-JAJWTYFOSA-N n-[(1r,2r,3r,4r,5r)-2,4-dihydroxy-6,8-dioxabicyclo[3.2.1]octan-3-yl]acetamide Chemical compound O1[C@@]2([H])OC[C@]1([H])[C@H](O)[C@@H](NC(C)=O)[C@H]2O TWDDETOCLAWUAT-JAJWTYFOSA-N 0.000 claims description 3
- VCCNKWWXYVWTLT-UHFFFAOYSA-N neodiosmin Natural products C1=C(O)C(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C=C2OC1C(OC2C(C(O)C(O)C(C)O2)O)C(O)C(O)C(CO)O1 VCCNKWWXYVWTLT-UHFFFAOYSA-N 0.000 claims description 3
- 229960005010 orotic acid Drugs 0.000 claims description 3
- 229920001983 poloxamer Polymers 0.000 claims description 3
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 3
- 235000019608 salt taste sensations Nutrition 0.000 claims description 3
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 3
- 229940013618 stevioside Drugs 0.000 claims description 3
- 235000019202 steviosides Nutrition 0.000 claims description 3
- 150000003460 sulfonic acids Chemical class 0.000 claims description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 3
- 229960002898 threonine Drugs 0.000 claims description 3
- 229940035893 uracil Drugs 0.000 claims description 3
- 229940116269 uric acid Drugs 0.000 claims description 3
- MRAJPHXZVBYJEU-PXEZKRLASA-N (2R,3S,5S,6R)-2-[(2S,3S,5S,6R)-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound [C@H]1([C@@H](O)C[C@H](O)[C@H](O1)CO)[C@@]1(O)[C@@H](O)C[C@H](O)[C@H](O1)CO MRAJPHXZVBYJEU-PXEZKRLASA-N 0.000 claims description 2
- HZQICOWWOIVVGP-HASVCBABSA-N (2S)-2-amino-4-methylsulfanyl-N-[(2R)-1-oxo-1-[(1,2,2,3-tetramethylcyclopentyl)amino]propan-2-yl]butanamide Chemical compound CC1CCC(C1(C)C)(C)NC(=O)[C@@H](C)NC(=O)[C@H](CCSC)N HZQICOWWOIVVGP-HASVCBABSA-N 0.000 claims description 2
- YEEFEWNECFNTEE-PVFLNQBWSA-N (2s,3r,4r,5s,6r)-6-(hydroxymethyl)-2,5-dimethoxyoxane-3,4-diol Chemical compound CO[C@H]1O[C@H](CO)[C@@H](OC)[C@H](O)[C@H]1O YEEFEWNECFNTEE-PVFLNQBWSA-N 0.000 claims description 2
- NUFKRGBSZPCGQB-FLBSXDLDSA-N (3s)-3-amino-4-oxo-4-[[(2r)-1-oxo-1-[(2,2,4,4-tetramethylthietan-3-yl)amino]propan-2-yl]amino]butanoic acid;pentahydrate Chemical compound O.O.O.O.O.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C NUFKRGBSZPCGQB-FLBSXDLDSA-N 0.000 claims description 2
- 239000004377 Alitame Substances 0.000 claims description 2
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 claims description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical class NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 claims description 2
- 229920001100 Polydextrose Polymers 0.000 claims description 2
- 239000004376 Sucralose Substances 0.000 claims description 2
- 229960005164 acesulfame Drugs 0.000 claims description 2
- 235000010358 acesulfame potassium Nutrition 0.000 claims description 2
- 108010009985 alitame Proteins 0.000 claims description 2
- 235000019409 alitame Nutrition 0.000 claims description 2
- 229930013930 alkaloid Natural products 0.000 claims description 2
- 229940061720 alpha hydroxy acid Drugs 0.000 claims description 2
- 150000001280 alpha hydroxy acids Chemical class 0.000 claims description 2
- 150000001371 alpha-amino acids Chemical class 0.000 claims description 2
- 235000008206 alpha-amino acids Nutrition 0.000 claims description 2
- 235000010323 ascorbic acid Nutrition 0.000 claims description 2
- 239000011668 ascorbic acid Substances 0.000 claims description 2
- 229960005070 ascorbic acid Drugs 0.000 claims description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 claims description 2
- 150000001576 beta-amino acids Chemical class 0.000 claims description 2
- 150000001789 chalcones Chemical class 0.000 claims description 2
- 235000005513 chalcones Nutrition 0.000 claims description 2
- 235000001671 coumarin Nutrition 0.000 claims description 2
- 150000004775 coumarins Chemical class 0.000 claims description 2
- 125000004387 flavanoid group Chemical group 0.000 claims description 2
- 150000002512 isocoumarins Chemical class 0.000 claims description 2
- IQZZFVDIZRWADY-UHFFFAOYSA-N isocumarine Natural products C1=CC=C2C(=O)OC=CC2=C1 IQZZFVDIZRWADY-UHFFFAOYSA-N 0.000 claims description 2
- CDAISMWEOUEBRE-GNIYUCBRSA-N muco-inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)[C@H]1O CDAISMWEOUEBRE-GNIYUCBRSA-N 0.000 claims description 2
- 239000001259 polydextrose Substances 0.000 claims description 2
- 229940035035 polydextrose Drugs 0.000 claims description 2
- 235000013856 polydextrose Nutrition 0.000 claims description 2
- 229930182490 saponin Natural products 0.000 claims description 2
- 150000007949 saponins Chemical class 0.000 claims description 2
- 235000017709 saponins Nutrition 0.000 claims description 2
- 235000011888 snacks Nutrition 0.000 claims description 2
- 150000003431 steroids Chemical class 0.000 claims description 2
- 235000019408 sucralose Nutrition 0.000 claims description 2
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 2
- 229940124530 sulfonamide Drugs 0.000 claims description 2
- 150000003456 sulfonamides Chemical class 0.000 claims description 2
- 235000019613 sensory perceptions of taste Nutrition 0.000 claims 5
- 230000035923 taste sensation Effects 0.000 claims 5
- CCVYRRGZDBSHFU-UHFFFAOYSA-N (2-hydroxyphenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC=C1O CCVYRRGZDBSHFU-UHFFFAOYSA-N 0.000 claims 4
- CFFZDZCDUFSOFZ-UHFFFAOYSA-N 3,4-Dihydroxy-phenylacetic acid Chemical compound OC(=O)CC1=CC=C(O)C(O)=C1 CFFZDZCDUFSOFZ-UHFFFAOYSA-N 0.000 claims 4
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 claims 4
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 claims 4
- JMSVCTWVEWCHDZ-UHFFFAOYSA-N syringic acid Chemical compound COC1=CC(C(O)=O)=CC(OC)=C1O JMSVCTWVEWCHDZ-UHFFFAOYSA-N 0.000 claims 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims 2
- SJJCQDRGABAVBB-UHFFFAOYSA-N 1-hydroxy-2-naphthoic acid Chemical compound C1=CC=CC2=C(O)C(C(=O)O)=CC=C21 SJJCQDRGABAVBB-UHFFFAOYSA-N 0.000 claims 2
- ZMCHBSMFKQYNKA-UHFFFAOYSA-N 2-aminobenzenesulfonic acid Chemical compound NC1=CC=CC=C1S(O)(=O)=O ZMCHBSMFKQYNKA-UHFFFAOYSA-N 0.000 claims 2
- HFCFJYRLBAANKN-UHFFFAOYSA-N 2-methyl-3-nitroaniline Chemical compound CC1=C(N)C=CC=C1[N+]([O-])=O HFCFJYRLBAANKN-UHFFFAOYSA-N 0.000 claims 2
- ALKYHXVLJMQRLQ-UHFFFAOYSA-N 3-Hydroxy-2-naphthoate Chemical compound C1=CC=C2C=C(O)C(C(=O)O)=CC2=C1 ALKYHXVLJMQRLQ-UHFFFAOYSA-N 0.000 claims 2
- VQZLZBCJGCUAET-UHFFFAOYSA-N 4-(2,4-dihydroxy-6-methylphenyl)-4-oxobutanoic acid Chemical compound CC1=CC(O)=CC(O)=C1C(=O)CCC(O)=O VQZLZBCJGCUAET-UHFFFAOYSA-N 0.000 claims 2
- ZEYHEAKUIGZSGI-UHFFFAOYSA-M 4-methoxybenzoate Chemical compound COC1=CC=C(C([O-])=O)C=C1 ZEYHEAKUIGZSGI-UHFFFAOYSA-M 0.000 claims 2
- BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 claims 2
- VCCNKWWXYVWTLT-CYZBKYQRSA-N 7-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)chromen-4-one Chemical compound C1=C(O)C(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C=C2O[C@H]1[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 VCCNKWWXYVWTLT-CYZBKYQRSA-N 0.000 claims 2
- 229930182843 D-Lactic acid Natural products 0.000 claims 2
- JVTAAEKCZFNVCJ-UWTATZPHSA-N D-lactic acid Chemical compound C[C@@H](O)C(O)=O JVTAAEKCZFNVCJ-UWTATZPHSA-N 0.000 claims 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims 2
- 229960004909 aminosalicylic acid Drugs 0.000 claims 2
- 239000001630 malic acid Substances 0.000 claims 2
- 235000011090 malic acid Nutrition 0.000 claims 2
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims 2
- TWDDETOCLAWUAT-OZRXBMAMSA-N n-[(1r,2s,3s,4r,5r)-2,4-dihydroxy-6,8-dioxabicyclo[3.2.1]octan-3-yl]acetamide Chemical compound O1[C@@]2([H])OC[C@]1([H])[C@@H](O)[C@H](NC(C)=O)[C@H]2O TWDDETOCLAWUAT-OZRXBMAMSA-N 0.000 claims 2
- 229920000056 polyoxyethylene ether Polymers 0.000 claims 2
- YIBXWXOYFGZLRU-UHFFFAOYSA-N syringic aldehyde Natural products CC12CCC(C3(CCC(=O)C(C)(C)C3CC=3)C)C=3C1(C)CCC2C1COC(C)(C)C(O)C(O)C1 YIBXWXOYFGZLRU-UHFFFAOYSA-N 0.000 claims 2
- KTCSQGWPHZTNEN-UOLFYFMNSA-N (2S,3R,4R,5S,6R)-6-(hydroxymethyl)-5-methoxy-2-methyloxane-2,3,4-triol Chemical compound C[C@@]1(O)[C@H](O)[C@@H](O)[C@H](OC)[C@H](O1)CO KTCSQGWPHZTNEN-UOLFYFMNSA-N 0.000 claims 1
- GBTNFNWWZMHORY-AXDSSHIGSA-N (3s)-3-amino-4-oxo-4-[1-[(2,2,5,5-tetramethylcyclopentanecarbonyl)amino]ethylamino]butanoic acid Chemical compound OC(=O)C[C@H](N)C(=O)NC(C)NC(=O)C1C(C)(C)CCC1(C)C GBTNFNWWZMHORY-AXDSSHIGSA-N 0.000 claims 1
- 235000005135 Micromeria juliana Nutrition 0.000 claims 1
- 241000246354 Satureja Species 0.000 claims 1
- 235000007315 Satureja hortensis Nutrition 0.000 claims 1
- 230000002708 enhancing effect Effects 0.000 claims 1
- 235000014214 soft drink Nutrition 0.000 claims 1
- 239000003638 chemical reducing agent Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 74
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 60
- 239000007864 aqueous solution Substances 0.000 description 57
- 229910052700 potassium Inorganic materials 0.000 description 37
- 239000011591 potassium Substances 0.000 description 36
- FWKRTJJKOAASQA-UHFFFAOYSA-M potassium;2,4-dihydroxybenzoate Chemical compound [K+].OC1=CC=C(C([O-])=O)C(O)=C1 FWKRTJJKOAASQA-UHFFFAOYSA-M 0.000 description 35
- 108020003175 receptors Proteins 0.000 description 35
- 206010013911 Dysgeusia Diseases 0.000 description 33
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical group [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 32
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 30
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 30
- 229960001948 caffeine Drugs 0.000 description 30
- 235000019605 sweet taste sensations Nutrition 0.000 description 30
- SKORRGYRKQDXRS-UHFFFAOYSA-M sodium;2-(4-methoxyphenoxy)propanoate Chemical compound [Na+].COC1=CC=C(OC(C)C([O-])=O)C=C1 SKORRGYRKQDXRS-UHFFFAOYSA-M 0.000 description 29
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 27
- 230000000694 effects Effects 0.000 description 24
- 239000000047 product Substances 0.000 description 18
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 17
- 238000002360 preparation method Methods 0.000 description 17
- 229910052708 sodium Inorganic materials 0.000 description 17
- 239000011734 sodium Substances 0.000 description 17
- 0 C1CC*CC1 Chemical compound C1CC*CC1 0.000 description 15
- 239000007787 solid Substances 0.000 description 15
- 230000009466 transformation Effects 0.000 description 15
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 14
- 230000009467 reduction Effects 0.000 description 14
- 238000012360 testing method Methods 0.000 description 13
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 12
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 11
- 230000002378 acidificating effect Effects 0.000 description 11
- 230000003247 decreasing effect Effects 0.000 description 11
- 230000008447 perception Effects 0.000 description 11
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 10
- 229930006000 Sucrose Natural products 0.000 description 10
- 229960001138 acetylsalicylic acid Drugs 0.000 description 10
- 230000015556 catabolic process Effects 0.000 description 10
- 239000000843 powder Substances 0.000 description 10
- 235000021451 refried beans Nutrition 0.000 description 10
- 239000005720 sucrose Substances 0.000 description 10
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 9
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 9
- 229910001414 potassium ion Inorganic materials 0.000 description 9
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- 125000002947 alkylene group Chemical group 0.000 description 8
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 8
- 235000000346 sugar Nutrition 0.000 description 8
- 244000299461 Theobroma cacao Species 0.000 description 7
- 230000000875 corresponding effect Effects 0.000 description 7
- 229930183009 gymnemic acid Natural products 0.000 description 7
- 235000010333 potassium nitrate Nutrition 0.000 description 7
- 239000004323 potassium nitrate Substances 0.000 description 7
- 235000013606 potato chips Nutrition 0.000 description 7
- 229910001415 sodium ion Inorganic materials 0.000 description 7
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Substances [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 6
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 6
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 6
- 125000002252 acyl group Chemical group 0.000 description 6
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 235000019219 chocolate Nutrition 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 125000000623 heterocyclic group Chemical group 0.000 description 6
- 229910001629 magnesium chloride Inorganic materials 0.000 description 6
- 235000011147 magnesium chloride Nutrition 0.000 description 6
- 235000013919 monopotassium glutamate Nutrition 0.000 description 6
- 125000003367 polycyclic group Chemical group 0.000 description 6
- NGSFWBMYFKHRBD-UHFFFAOYSA-M sodium lactate Chemical compound [Na+].CC(O)C([O-])=O NGSFWBMYFKHRBD-UHFFFAOYSA-M 0.000 description 6
- 238000000844 transformation Methods 0.000 description 6
- 239000004474 valine Substances 0.000 description 6
- 235000013311 vegetables Nutrition 0.000 description 6
- 230000000903 blocking effect Effects 0.000 description 5
- 230000008030 elimination Effects 0.000 description 5
- 238000003379 elimination reaction Methods 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 230000000873 masking effect Effects 0.000 description 5
- 150000002772 monosaccharides Chemical class 0.000 description 5
- 229920001542 oligosaccharide Polymers 0.000 description 5
- 150000002482 oligosaccharides Chemical class 0.000 description 5
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 5
- LXBILIBIMQVTQT-UHFFFAOYSA-M potassium;2,4,6-trihydroxybenzoate Chemical compound [K+].OC1=CC(O)=C(C([O-])=O)C(O)=C1 LXBILIBIMQVTQT-UHFFFAOYSA-M 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 159000000000 sodium salts Chemical class 0.000 description 5
- 230000036327 taste response Effects 0.000 description 5
- 241000251468 Actinopterygii Species 0.000 description 4
- 240000004160 Capsicum annuum Species 0.000 description 4
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 125000005251 aryl acyl group Chemical group 0.000 description 4
- 125000004104 aryloxy group Chemical group 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 235000013877 carbamide Nutrition 0.000 description 4
- 238000007385 chemical modification Methods 0.000 description 4
- 229960004126 codeine Drugs 0.000 description 4
- 125000004093 cyano group Chemical group *C#N 0.000 description 4
- 235000019688 fish Nutrition 0.000 description 4
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 4
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 4
- 235000013372 meat Nutrition 0.000 description 4
- 239000004239 monopotassium glutamate Substances 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 229960005489 paracetamol Drugs 0.000 description 4
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 4
- 235000010235 potassium benzoate Nutrition 0.000 description 4
- 239000004300 potassium benzoate Substances 0.000 description 4
- 229940103091 potassium benzoate Drugs 0.000 description 4
- 239000011736 potassium bicarbonate Substances 0.000 description 4
- 235000015497 potassium bicarbonate Nutrition 0.000 description 4
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 4
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 4
- 235000010289 potassium nitrite Nutrition 0.000 description 4
- 239000004304 potassium nitrite Substances 0.000 description 4
- HQEROMHPIOLGCB-DFWYDOINSA-M potassium;(2s)-2-aminopentanedioate;hydron Chemical compound [K+].[O-]C(=O)[C@@H](N)CCC(O)=O HQEROMHPIOLGCB-DFWYDOINSA-M 0.000 description 4
- APLQINJPEOPNLI-FJXQXJEOSA-M potassium;2-[[(2s)-2-amino-3-carboxypropanoyl]amino]benzoate Chemical compound [K+].OC(=O)C[C@H](N)C(=O)NC1=CC=CC=C1C([O-])=O APLQINJPEOPNLI-FJXQXJEOSA-M 0.000 description 4
- 244000144977 poultry Species 0.000 description 4
- 235000013594 poultry meat Nutrition 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 235000019600 saltiness Nutrition 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- 235000010288 sodium nitrite Nutrition 0.000 description 4
- 150000004043 trisaccharides Chemical class 0.000 description 4
- 206010006784 Burning sensation Diseases 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- 108010016626 Dipeptides Proteins 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 3
- 229910006074 SO2NH2 Inorganic materials 0.000 description 3
- 229910006069 SO3H Inorganic materials 0.000 description 3
- AZFNGPAYDKGCRB-XCPIVNJJSA-M [(1s,2s)-2-amino-1,2-diphenylethyl]-(4-methylphenyl)sulfonylazanide;chlororuthenium(1+);1-methyl-4-propan-2-ylbenzene Chemical compound [Ru+]Cl.CC(C)C1=CC=C(C)C=C1.C1=CC(C)=CC=C1S(=O)(=O)[N-][C@@H](C=1C=CC=CC=1)[C@@H](N)C1=CC=CC=C1 AZFNGPAYDKGCRB-XCPIVNJJSA-M 0.000 description 3
- WAJYOAVKNGUXRF-UHFFFAOYSA-N [(4-cyanophenyl)carbamoylamino]methanesulfonic acid Chemical compound OS(=O)(=O)CNC(=O)NC1=CC=C(C#N)C=C1 WAJYOAVKNGUXRF-UHFFFAOYSA-N 0.000 description 3
- 125000000266 alpha-aminoacyl group Chemical group 0.000 description 3
- 230000004075 alteration Effects 0.000 description 3
- 230000003466 anti-cipated effect Effects 0.000 description 3
- 229960005261 aspartic acid Drugs 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 235000019611 bitter taste sensations Nutrition 0.000 description 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 3
- 150000003857 carboxamides Chemical class 0.000 description 3
- 235000016213 coffee Nutrition 0.000 description 3
- 235000013353 coffee beverage Nutrition 0.000 description 3
- 235000020057 cognac Nutrition 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 235000021458 diet cola Nutrition 0.000 description 3
- 150000002016 disaccharides Chemical class 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 235000010855 food raising agent Nutrition 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 150000002338 glycosides Chemical class 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 150000002367 halogens Chemical class 0.000 description 3
- 229960001680 ibuprofen Drugs 0.000 description 3
- 150000004702 methyl esters Chemical class 0.000 description 3
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 3
- 235000013923 monosodium glutamate Nutrition 0.000 description 3
- 239000004223 monosodium glutamate Substances 0.000 description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 235000015277 pork Nutrition 0.000 description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 description 3
- 159000000001 potassium salts Chemical class 0.000 description 3
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 3
- 229910052939 potassium sulfate Inorganic materials 0.000 description 3
- 235000011151 potassium sulphates Nutrition 0.000 description 3
- 235000019252 potassium sulphite Nutrition 0.000 description 3
- NQAKELUIIYZFFT-QRPNPIFTSA-M potassium;4-[[(2s)-2-amino-3-carboxypropanoyl]amino]benzoate Chemical compound [K+].OC(=O)C[C@H](N)C(=O)NC1=CC=C(C([O-])=O)C=C1 NQAKELUIIYZFFT-QRPNPIFTSA-M 0.000 description 3
- 235000015067 sauces Nutrition 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 235000019615 sensations Nutrition 0.000 description 3
- ZGIYTLGBDAOYFL-UHFFFAOYSA-M sodium;2,4-dihydroxybenzoate Chemical compound [Na+].OC1=CC=C(C([O-])=O)C(O)=C1 ZGIYTLGBDAOYFL-UHFFFAOYSA-M 0.000 description 3
- 235000019583 umami taste Nutrition 0.000 description 3
- 150000003672 ureas Chemical class 0.000 description 3
- YXDMSFJDVHXFCV-UHFFFAOYSA-N 1,1,2,2-tetramethylcyclopentane Chemical class CC1(C)CCCC1(C)C YXDMSFJDVHXFCV-UHFFFAOYSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- 241000234282 Allium Species 0.000 description 2
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 2
- 240000002234 Allium sativum Species 0.000 description 2
- 235000007862 Capsicum baccatum Nutrition 0.000 description 2
- 235000002568 Capsicum frutescens Nutrition 0.000 description 2
- 239000001692 EU approved anti-caking agent Substances 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 2
- 208000025371 Taste disease Diseases 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 125000004442 acylamino group Chemical group 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 2
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 description 2
- 125000003282 alkyl amino group Chemical group 0.000 description 2
- 125000005910 alkyl carbonate group Chemical class 0.000 description 2
- 150000001409 amidines Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 125000005100 aryl amino carbonyl group Chemical group 0.000 description 2
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 235000015895 biscuits Nutrition 0.000 description 2
- 239000001511 capsicum annuum Substances 0.000 description 2
- 239000001728 capsicum frutescens Substances 0.000 description 2
- 229940077731 carbohydrate nutrients Drugs 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 2
- 150000001733 carboxylic acid esters Chemical class 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 235000013351 cheese Nutrition 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 125000004663 dialkyl amino group Chemical group 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- WDRWZVWLVBXVOI-QTNFYWBSSA-L dipotassium;(2s)-2-aminopentanedioate Chemical compound [K+].[K+].[O-]C(=O)[C@@H](N)CCC([O-])=O WDRWZVWLVBXVOI-QTNFYWBSSA-L 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- ZINJLDJMHCUBIP-UHFFFAOYSA-N ethametsulfuron-methyl Chemical compound CCOC1=NC(NC)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)C(=O)OC)=N1 ZINJLDJMHCUBIP-UHFFFAOYSA-N 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 239000000834 fixative Substances 0.000 description 2
- 235000004611 garlic Nutrition 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 125000001165 hydrophobic group Chemical group 0.000 description 2
- 150000001261 hydroxy acids Chemical class 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 150000002596 lactones Chemical class 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000013575 mashed potatoes Nutrition 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 235000019656 metallic taste Nutrition 0.000 description 2
- VSDUZFOSJDMAFZ-VIFPVBQESA-N methyl L-phenylalaninate Chemical compound COC(=O)[C@@H](N)CC1=CC=CC=C1 VSDUZFOSJDMAFZ-VIFPVBQESA-N 0.000 description 2
- 125000004092 methylthiomethyl group Chemical group [H]C([H])([H])SC([H])([H])* 0.000 description 2
- YCWSUKQGVSGXJO-NTUHNPAUSA-N nifuroxazide Chemical group C1=CC(O)=CC=C1C(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 YCWSUKQGVSGXJO-NTUHNPAUSA-N 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 235000012771 pancakes Nutrition 0.000 description 2
- 235000011181 potassium carbonates Nutrition 0.000 description 2
- 229940034483 potassium chloride / sodium chloride Drugs 0.000 description 2
- BHZRJJOHZFYXTO-UHFFFAOYSA-L potassium sulfite Chemical compound [K+].[K+].[O-]S([O-])=O BHZRJJOHZFYXTO-UHFFFAOYSA-L 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 235000013613 poultry product Nutrition 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 230000030812 sensory perception of bitter taste Effects 0.000 description 2
- 230000014860 sensory perception of taste Effects 0.000 description 2
- HELHAJAZNSDZJO-OLXYHTOASA-L sodium L-tartrate Chemical compound [Na+].[Na+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O HELHAJAZNSDZJO-OLXYHTOASA-L 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 239000001433 sodium tartrate Substances 0.000 description 2
- 229960002167 sodium tartrate Drugs 0.000 description 2
- 235000011004 sodium tartrates Nutrition 0.000 description 2
- JEBJUZXTDWZHGG-UHFFFAOYSA-M sodium;2,4,6-trihydroxybenzoate Chemical compound [Na+].OC1=CC(O)=C(C([O-])=O)C(O)=C1 JEBJUZXTDWZHGG-UHFFFAOYSA-M 0.000 description 2
- JZLOKWGVGHYBKD-UHFFFAOYSA-M sodium;2-acetyloxybenzoate Chemical compound [Na+].CC(=O)OC1=CC=CC=C1C([O-])=O JZLOKWGVGHYBKD-UHFFFAOYSA-M 0.000 description 2
- 235000019614 sour taste Nutrition 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 125000005415 substituted alkoxy group Chemical group 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 125000000565 sulfonamide group Chemical group 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 125000004954 trialkylamino group Chemical group 0.000 description 2
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 2
- 235000015041 whisky Nutrition 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- YDKJIXUDXQGUKA-VLVWQGGMSA-N (3S)-3-amino-4-[[1-[(2S)-2-aminopropanoyl]-2,2,3,3-tetramethylcyclopentyl]amino]-4-oxobutanoic acid Chemical compound C[C@@H](C(=O)C1(CCC(C1(C)C)(C)C)NC(=O)[C@H](CC(=O)O)N)N YDKJIXUDXQGUKA-VLVWQGGMSA-N 0.000 description 1
- YLBDXTRZQKEMDS-UWVGGRQHSA-N (3S)-3-amino-4-[[1-[(2S)-2-aminopropanoyl]-2,2,5,5-tetramethylcyclopentyl]amino]-4-oxobutanoic acid Chemical compound C[C@@H](C(=O)C1(C(CCC1(C)C)(C)C)NC(=O)[C@H](CC(=O)O)N)N YLBDXTRZQKEMDS-UWVGGRQHSA-N 0.000 description 1
- OEOUMLJIXFDCEP-OUBLUOKUSA-N (3S)-3-amino-4-oxo-4-[[(2R)-1-oxo-1-[(1,2,2,3-tetramethylcyclopentyl)amino]propan-2-yl]amino]butanoic acid Chemical compound CC1CCC(C1(C)C)(C)NC(=O)[C@@H](C)NC(=O)[C@H](CC(=O)O)N OEOUMLJIXFDCEP-OUBLUOKUSA-N 0.000 description 1
- MAYZWDRUFKUGGP-VIFPVBQESA-N (3s)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol Chemical compound CN1N=NN=C1CN1C2=NC(C(C)(C)C)=NC(N3C[C@@H](O)CC3)=C2N=N1 MAYZWDRUFKUGGP-VIFPVBQESA-N 0.000 description 1
- KNIZBZYMVRWQKN-DMTCNVIQSA-N (3s)-3-amino-4-[[(2r)-1-amino-1-oxopropan-2-yl]amino]-4-oxobutanoic acid Chemical class NC(=O)[C@@H](C)NC(=O)[C@@H](N)CC(O)=O KNIZBZYMVRWQKN-DMTCNVIQSA-N 0.000 description 1
- VHIHLCXLJNGZNZ-UDPKNTEWSA-N (3s)-3-amino-4-oxo-4-[[(1r)-1-[(1,2,2,3-tetramethylcyclopentanecarbonyl)amino]ethyl]amino]butanoic acid Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C)NC(=O)C1(C)CCC(C)C1(C)C VHIHLCXLJNGZNZ-UDPKNTEWSA-N 0.000 description 1
- GBTNFNWWZMHORY-UWVGGRQHSA-N (3s)-3-amino-4-oxo-4-[[(1r)-1-[(2,2,5,5-tetramethylcyclopentanecarbonyl)amino]ethyl]amino]butanoic acid Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C)NC(=O)C1C(C)(C)CCC1(C)C GBTNFNWWZMHORY-UWVGGRQHSA-N 0.000 description 1
- VHIHLCXLJNGZNZ-OUBLUOKUSA-N (3s)-3-amino-4-oxo-4-[[(1s)-1-[(1,2,2,3-tetramethylcyclopentanecarbonyl)amino]ethyl]amino]butanoic acid Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](C)NC(=O)C1(C)CCC(C)C1(C)C VHIHLCXLJNGZNZ-OUBLUOKUSA-N 0.000 description 1
- SQLJHWMWPDFSIG-ZJUUUORDSA-N (3s)-3-amino-4-oxo-4-[[(2r)-1-oxo-1-[(2,2,5,5-tetramethylcyclopentyl)amino]propan-2-yl]amino]butanoic acid Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)CCC1(C)C SQLJHWMWPDFSIG-ZJUUUORDSA-N 0.000 description 1
- MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 1
- APWRZPQBPCAXFP-UHFFFAOYSA-N 1-(1-oxo-2H-isoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)pyridin-4-yl]pyrazole-4-carboxamide Chemical compound O=C1NC=CC2=C(C=CC=C12)N1N=CC(=C1C(F)(F)F)C(=O)NC1=CC(=NC=C1)C(F)(F)F APWRZPQBPCAXFP-UHFFFAOYSA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 description 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
- BYHQTRFJOGIQAO-GOSISDBHSA-N 3-(4-bromophenyl)-8-[(2R)-2-hydroxypropyl]-1-[(3-methoxyphenyl)methyl]-1,3,8-triazaspiro[4.5]decan-2-one Chemical compound C[C@H](CN1CCC2(CC1)CN(C(=O)N2CC3=CC(=CC=C3)OC)C4=CC=C(C=C4)Br)O BYHQTRFJOGIQAO-GOSISDBHSA-N 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- IRPVABHDSJVBNZ-RTHVDDQRSA-N 5-[1-(cyclopropylmethyl)-5-[(1R,5S)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl]pyrazol-3-yl]-3-(trifluoromethyl)pyridin-2-amine Chemical compound C1=C(C(F)(F)F)C(N)=NC=C1C1=NN(CC2CC2)C(C2[C@@H]3CN(C[C@@H]32)C2COC2)=C1 IRPVABHDSJVBNZ-RTHVDDQRSA-N 0.000 description 1
- KCBWAFJCKVKYHO-UHFFFAOYSA-N 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine Chemical compound C1(CC1)C1=NC=NC(=C1C1=NC=C2C(=N1)N(N=C2)CC1=CC=C(C=C1)C=1N(C=C(N=1)C(F)(F)F)C(C)C)OC KCBWAFJCKVKYHO-UHFFFAOYSA-N 0.000 description 1
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- FVVDKUPCWXUVNP-UHFFFAOYSA-M Aminosalicylate sodium anhydrous Chemical compound [Na+].NC1=CC=C(C([O-])=O)C(O)=C1 FVVDKUPCWXUVNP-UHFFFAOYSA-M 0.000 description 1
- DVUFTQLHHHJEMK-IMJSIDKUSA-N Asp-Ala Chemical class OC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O DVUFTQLHHHJEMK-IMJSIDKUSA-N 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- NIKHGUQULKYIGE-MOWPSDGOSA-N C[C@](CCC1)(C(CCC(C2)C(C3)=C)C23CC2)C2[C@]1(C)C(O)=O Chemical compound C[C@](CCC1)(C(CCC(C2)C(C3)=C)C23CC2)C2[C@]1(C)C(O)=O NIKHGUQULKYIGE-MOWPSDGOSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 241000861718 Chloris <Aves> Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 239000004097 EU approved flavor enhancer Substances 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- KOSRFJWDECSPRO-WDSKDSINSA-N Glu-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O KOSRFJWDECSPRO-WDSKDSINSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- GRSZFWQUAKGDAV-KQYNXXCUSA-L IMP(2-) Chemical compound O[C@@H]1[C@H](O)[C@@H](COP([O-])([O-])=O)O[C@H]1N1C(N=CNC2=O)=C2N=C1 GRSZFWQUAKGDAV-KQYNXXCUSA-L 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- 238000012565 NMR experiment Methods 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical class [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 239000006057 Non-nutritive feed additive Substances 0.000 description 1
- IDRGFNPZDVBSSE-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F Chemical compound OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F IDRGFNPZDVBSSE-UHFFFAOYSA-N 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- BRDYYVQTEJVRQT-HRCADAONSA-N Phe-Arg-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)O BRDYYVQTEJVRQT-HRCADAONSA-N 0.000 description 1
- GKZIWHRNKRBEOH-HOTGVXAUSA-N Phe-Phe Chemical compound C([C@H]([NH3+])C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)C1=CC=CC=C1 GKZIWHRNKRBEOH-HOTGVXAUSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical class [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 1
- LIHSGVYUACASAV-YGYANBGASA-J [C+4].N[C@@H](CC(=O)O)C(=O)C(=O)[O-].N[C@@H](CC(=O)O)C(=O)C(=O)[O-].N[C@@H](CC(=O)O)C(=O)C(=O)[O-].N[C@@H](CC(=O)O)C(=O)C(=O)[O-] Chemical group [C+4].N[C@@H](CC(=O)O)C(=O)C(=O)[O-].N[C@@H](CC(=O)O)C(=O)C(=O)[O-].N[C@@H](CC(=O)O)C(=O)C(=O)[O-].N[C@@H](CC(=O)O)C(=O)C(=O)[O-] LIHSGVYUACASAV-YGYANBGASA-J 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001323 aldoses Chemical class 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 235000015173 baked goods and baking mixes Nutrition 0.000 description 1
- 229940050390 benzoate Drugs 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical class OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 229960002246 beta-d-glucopyranose Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000015123 black coffee Nutrition 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 235000012839 cake mixes Nutrition 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000012174 carbonated soft drink Nutrition 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000571 coke Substances 0.000 description 1
- 230000006957 competitive inhibition Effects 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- RKTYLMNFRDHKIL-UHFFFAOYSA-N copper;5,10,15,20-tetraphenylporphyrin-22,24-diide Chemical compound [Cu+2].C1=CC(C(=C2C=CC([N-]2)=C(C=2C=CC=CC=2)C=2C=CC(N=2)=C(C=2C=CC=CC=2)C2=CC=C3[N-]2)C=2C=CC=CC=2)=NC1=C3C1=CC=CC=C1 RKTYLMNFRDHKIL-UHFFFAOYSA-N 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 229940109275 cyclamate Drugs 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- GZSOSUNBTXMUFQ-YFAPSIMESA-N diosmin Chemical compound C1=C(O)C(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 GZSOSUNBTXMUFQ-YFAPSIMESA-N 0.000 description 1
- WPUMTJGUQUYPIV-JIZZDEOASA-L disodium (S)-malate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](O)CC([O-])=O WPUMTJGUQUYPIV-JIZZDEOASA-L 0.000 description 1
- XMXOIHIZTOVVFB-YBBRRFGFSA-L disodium;(2r)-2-aminobutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)[C@H](N)CC([O-])=O XMXOIHIZTOVVFB-YBBRRFGFSA-L 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 150000002085 enols Chemical class 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 235000015114 espresso Nutrition 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 150000005574 ethoxybenzenes Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000013332 fish product Nutrition 0.000 description 1
- 235000010037 flour treatment agent Nutrition 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000019264 food flavour enhancer Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000019249 food preservative Nutrition 0.000 description 1
- 239000005452 food preservative Substances 0.000 description 1
- 235000013569 fruit product Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 150000002243 furanoses Chemical group 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 235000021474 generally recognized As safe (food) Nutrition 0.000 description 1
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 229940049906 glutamate Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 150000002584 ketoses Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229960003390 magnesium sulfate Drugs 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- VSDUZFOSJDMAFZ-SECBINFHSA-N methyl (2r)-2-amino-3-phenylpropanoate Chemical compound COC(=O)[C@H](N)CC1=CC=CC=C1 VSDUZFOSJDMAFZ-SECBINFHSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- LPUQAYUQRXPFSQ-AENDTGMFSA-M monosodium D-glutamate Chemical compound [Na+].[O-]C(=O)[C@H]([NH3+])CCC([O-])=O LPUQAYUQRXPFSQ-AENDTGMFSA-M 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- QFCSRGLEMDRBMN-UHFFFAOYSA-N n-(2-methylphenyl)nitramide Chemical compound CC1=CC=CC=C1N[N+]([O-])=O QFCSRGLEMDRBMN-UHFFFAOYSA-N 0.000 description 1
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 1
- 229940052490 naringin Drugs 0.000 description 1
- 229930019673 naringin Natural products 0.000 description 1
- GWUSZQUVEVMBPI-UHFFFAOYSA-N nimetazepam Chemical compound N=1CC(=O)N(C)C2=CC=C([N+]([O-])=O)C=C2C=1C1=CC=CC=C1 GWUSZQUVEVMBPI-UHFFFAOYSA-N 0.000 description 1
- 238000006396 nitration reaction Methods 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 230000006959 non-competitive inhibition Effects 0.000 description 1
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 108010073025 phenylalanylphenylalanine Proteins 0.000 description 1
- 235000007686 potassium Nutrition 0.000 description 1
- KZDHTJOQWFLNBV-UHFFFAOYSA-M potassium;2,6-dihydroxybenzoate Chemical compound [K+].OC1=CC=CC(O)=C1C([O-])=O KZDHTJOQWFLNBV-UHFFFAOYSA-M 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 235000012434 pretzels Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 150000008383 propoxybenzenes Chemical class 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000003214 pyranose derivatives Chemical group 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000030738 sensory perception of sweet taste Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000019265 sodium DL-malate Nutrition 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 239000001394 sodium malate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- PZMRMUOIKLGCDL-UHFFFAOYSA-M sodium syringate Chemical compound [Na+].COC1=CC(C([O-])=O)=CC(OC)=C1O PZMRMUOIKLGCDL-UHFFFAOYSA-M 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- SWQYFLFAUHYVLM-UHFFFAOYSA-M sodium;1-hydroxynaphthalene-2-carboxylate Chemical compound [Na+].C1=CC=C2C(O)=C(C([O-])=O)C=CC2=C1 SWQYFLFAUHYVLM-UHFFFAOYSA-M 0.000 description 1
- NTAHVQPVJZSMSA-UHFFFAOYSA-M sodium;2-(2-hydroxyphenyl)acetate Chemical compound [Na+].OC1=CC=CC=C1CC([O-])=O NTAHVQPVJZSMSA-UHFFFAOYSA-M 0.000 description 1
- XVEWOBVHDMTDOZ-UHFFFAOYSA-M sodium;2-(3,4-dihydroxyphenyl)acetate Chemical compound [Na+].OC1=CC=C(CC([O-])=O)C=C1O XVEWOBVHDMTDOZ-UHFFFAOYSA-M 0.000 description 1
- FEGFRWRQHLWEJN-UHFFFAOYSA-M sodium;2-(3-methoxyphenyl)acetate Chemical compound [Na+].COC1=CC=CC(CC([O-])=O)=C1 FEGFRWRQHLWEJN-UHFFFAOYSA-M 0.000 description 1
- KYXOYPPMBYKBFL-UHFFFAOYSA-M sodium;2-aminobenzenesulfonate Chemical compound [Na+].NC1=CC=CC=C1S([O-])(=O)=O KYXOYPPMBYKBFL-UHFFFAOYSA-M 0.000 description 1
- HCKKSLZDSNNSTL-UHFFFAOYSA-M sodium;2-aminobenzoate Chemical compound [Na+].NC1=CC=CC=C1C([O-])=O HCKKSLZDSNNSTL-UHFFFAOYSA-M 0.000 description 1
- WPTJBFNYRRZIDZ-UHFFFAOYSA-M sodium;2-phenoxyacetate Chemical compound [Na+].[O-]C(=O)COC1=CC=CC=C1 WPTJBFNYRRZIDZ-UHFFFAOYSA-M 0.000 description 1
- ZCNGWQCRXUGQCW-UHFFFAOYSA-M sodium;3-hydroxynaphthalene-2-carboxylate Chemical compound [Na+].C1=CC=C2C=C(C([O-])=O)C(O)=CC2=C1 ZCNGWQCRXUGQCW-UHFFFAOYSA-M 0.000 description 1
- AETSDHMVQHOYPB-UHFFFAOYSA-M sodium;4-methoxybenzoate Chemical compound [Na+].COC1=CC=C(C([O-])=O)C=C1 AETSDHMVQHOYPB-UHFFFAOYSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 125000000185 sucrose group Chemical group 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 125000004354 sulfur functional group Chemical group 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 125000004149 thio group Chemical group *S* 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 150000003641 trioses Chemical class 0.000 description 1
- 235000021101 unsweetened yogurt Nutrition 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
- A23L27/37—Halogenated sugars
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/20—Synthetic spices, flavouring agents or condiments
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/20—Synthetic spices, flavouring agents or condiments
- A23L27/202—Aliphatic compounds
- A23L27/2024—Aliphatic compounds having oxygen as the only hetero atom
- A23L27/2028—Carboxy compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/20—Synthetic spices, flavouring agents or condiments
- A23L27/203—Alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/20—Synthetic spices, flavouring agents or condiments
- A23L27/204—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/20—Synthetic spices, flavouring agents or condiments
- A23L27/205—Heterocyclic compounds
- A23L27/2052—Heterocyclic compounds having oxygen or sulfur as the only hetero atoms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/20—Synthetic spices, flavouring agents or condiments
- A23L27/205—Heterocyclic compounds
- A23L27/2054—Heterocyclic compounds having nitrogen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/20—Synthetic spices, flavouring agents or condiments
- A23L27/21—Synthetic spices, flavouring agents or condiments containing amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/31—Artificial sweetening agents containing amino acids, nucleotides, peptides or derivatives
- A23L27/32—Artificial sweetening agents containing amino acids, nucleotides, peptides or derivatives containing dipeptides or derivatives
Definitions
- This invention relates in general to taste modifying compounds. More particularly it relates to tastands, as such term is used hereinbelow, to reduce or eliminate undesirable tastes, as such term is used hereinbelow.
- Such eatables as for example, pharmaceuticals, antibiotics, pain killers, aspirin, codeine, ibuprofen, acetaminophen, caffeine, and unsweetened chocolate, and sweeteners, as such term is used hereinbelow, can have their undesirable tastes, as such term is used hereinbelow, reduced and/or eliminated as well as having their
- undesirable taste (s) shall mean any taste which is sweet, bitter, sour, alkaline, astringent, tangy, dry, sharp, cool, hot, burning, acidic, spicy, pungent, woody, smokey, umami and/or metallic.
- undesirable taste shall include any and all tastes, if such taste (s) is unwanted and include any and all aftertaste(s), if such aftertaste is unwanted.
- caffeine may have little or no effect on a pharmaceutical and/or the off-taste of KCl, or,
- L-aspartyl-L-phenylalanine methyl ester may have little or no effect on the off-taste of another high intensity sweetener such as saccharin.
- L-Aspartyl-L-phenylalanine will have a substantial effect on the off-taste associated with L-aspartyl-L- phenylalanine methyl ester (Aspartame ® ), while it has less effect on the off-taste associated with
- Taurine has a substantial effect on the off-taste of saccharin while it has little or no effect on the off-taste associated with L-aspartyl-L-phenylalanine methyl ester (Aspartame ® ).
- a "taste” shall mean any taste which is salty, bitter, sweet, sour, alkaline, umami, astringent, tangy, dry, sharp, cool, hot, burning, acidic, spicy, pungent and/or metallic. Such taste shall include any and all taste(s) as well as any and all aftertaste(s). Once again this list is not all inclusive as one skilled in the art would recognize.
- an "eatable(s)" shall mean any material ingested. Eatables shall include, but not be limited, to materials ingested by humans, other mammals, fish, birds, and other animals.
- substantially tasteless as used herein and the appended claims is meant a compound that has substantially no taste upon initial ingestion at the levels that are appropriate to be a tastand.
- sweetener as used herein and the
- A. monosaccharides including but not limited to aldoses and ketoses beginning with trioses, including but not limited to glucose, galactose, and fructose,
- oligosaccharides including but not limited to sucrose, maltose, lactose, etc,
- sugar alcohols which include but are not limited to sorbitol, mannitol, glycerol,
- D. carbohydrates and polysaccharides which include but are not limited to polydextrose and maltodextrin,
- high intensity sweeteners shall include but are not limited to:
- L-aspartyl-L-phenylalanine methyl ester (Aspartame ® ) and other related dipeptide sweeteners, saccharin, L- aspartyl-D-alanine-N-(2,2,4,4-tetramethyl thiatan-3- yl)amide (Alitame ® ), 1,6-dichloro-1,6-dideoxy- ⁇ -D- fructofuranoysl-4-chloro-4-deoxy- ⁇ -D-galactopyranoside (Sucralose ® ), 6-methyl-1,2,3-oxathiazin-4(3H)-one 2,2- dioxide (Acesulfame ® ), 6-methyl-1,2,3-oxathiazin- 4(3H)-one 2,2-dioxide potassium salt (Acesulfame-K ® ), cyclohexylsulfamic acid (Cyclamate ® ), N-(L-aspartyl)- N'
- sweeteners dihydrochalcone class sweeteners
- low intensity sweetener as used herein and the appended claims is meant any sweetener except a high intensity sweeteners.
- masker any flavorful eatable which is used to cover and/or disguise and/or obscure an undesirable taste.
- eatables which are commonly used as maskers are sweeteners and spices such as onion, garlic, paprika, red pepper, chili powder, etc.
- low calorie eatable or "low calorie formulation” as used herein and the appended claims is meant any eatable in which the eatable has been purposely formulated for the reduced calorie market. Typically this has resulted in greater than twenty-five percent (>25%) of the calories having been removed from said eatable that would have been present in the regular non-low calorie formulation.
- X represents H, CHO ,
- Tastands can also be salt tastands. Tastands have the property that they will block one undesirable taste for example, bitter, and/or in some cases at the same time another undesirable taste. A specific tastand may have its own particular taste but its ability to block an
- Tastands may uncover tastes and/or off-tastes that were present in the eatable before the addition of the tastand.
- a tastand will not introduce any substantial taste and/or off-taste of its own. This property differentiates tastands from masking materials. For example to determine if a tastand is a bitter blocker it could be added to a solution of a bitter material such as KCl. If the material is a tastand it will block or substantially reduce the undesirable taste of KCl before it imparts any significant taste of its own. It is understood that a tastand may have the ability to block one undesirable taste more effectively than another undesirable taste.
- Some tastands may block only one undesirable taste effectively.
- a given tastand may, for example, block the perception of bitter at a level of 10-20 ppm but require 1000-10,000 ppm in order to effectively block another undesirable taste and/or tastes or it may not block the perception of another undesirable taste or tastes at any concentration. This relative effectiveness or inability to block certain tastes at all will vary from tastand to tastand and/or with concentration of the same tastand.
- Some specific tastands may block tastes that are not undesirable in certain specific applications such as sweet. Some tastands when added to an eatable may increase the
- the perception of another taste for example the level of saltiness of the eatable.
- the blocking of an undesirable taste may allow in some cases an increased sensation of another taste.
- the increased salt sensation that is perceived by the addition of a tastand is allowing the tastand to act as if it were a salt enhancer.
- salt tastand as used herein and in the appended claims means a tastand which, is itself salty or is
- salty eatables that could be used with a tastand to make a salt tastand would be NaCl, KCl, or NH 4 Cl.
- the solubility of the tastand in water may not be sufficient to demonstrate the blocking ability. In this case the tastand's solubility could be increased by the use of other substances to help this lack of solubility.
- Ethyl alcohol is one example of a material which can be used to increase the solubility of potential tastands to be used in the above referenced tastand test.
- a "surfactant” shall mean an amphipathic molecule.
- Such surface active agents shall include but not be limited to soaps, and/or detergents, whether ionic or non-ionic, and/or membrane lipids.
- surfactants may affect each tastand differently.
- the surfactant that affects one particular tastand in a positive, negative or neutral sense may affect another tastand differently (i.e. a positive, negative or neutral sense and not necessarily in the same way).
- potassium 2,4-dihydroxybenzoate is combined with KCl at, for example, 0.25% to 0.50% by weight relative to the KCl (depending upon the individual's sensitivity to bitter) it will virtually eliminate the bitterness associated with the potassium chloride. (This means that in an eatable
- Potassium 2,4-dihydroxybenzoate is also a tastand for the metallic taste associated with saccharin. If 25 to 50 milligrams of potassium 2,4-dihydroxybenzoate is added to a can of soda sweetened with saccharin (69 to 138 ppm of potassium 2,4-dihydroxybenzoate relative to the soda) the metallic taste is substantially reduced or eliminated allowing other flavors in the soda to come through. In the above examples (25-138 ppm) potassium 2,4- dihydroxybenzoate is a tastand because of its ability to block bitter taste at concentrations where it by itself is substantially tasteless.
- Potassium 2,4-dihydroxybenzoate is sweet only at significantly higher concentrations.
- sucrose is not a tastand in that a 2% solution is sweet but even at this level the bitterness of KCl is not substantially diminished.
- Sucrose would be a masking material under the current definitions.
- Proteins and peptides such as skim milk, soybean casein, whey protein concentrate or casein
- Case studies 2-4 were based on a strategy of the direct interaction of the additive with the undesirable taste component of an eatable in order to prevent said undesirable taste component from reaching the bitter taste receptor.
- case study 5 the authors used molar
- a tastand as defined hereinabove, can prevent bitter components from interacting with the taste receptor at concentrations where the tastand is tasteless or substantially tasteless. Prevention is by a direct interaction with the receptor site, as such term is used herein, to prevent or substantially eliminate:
- taurine is added to a can of soda (354 mL of per can; 28 ppm taurine) sweetened only with saccharin the off-taste of the saccharin is substantially reduced or eliminated, while the sweet taste is relatively unaltered.
- the present teaching is analogous to a competitive inhibition with a binding site of the receptor(s) and/or a non-competitive inhibition with the site(s) that influences the receptor.
- one of our teachings is that the tastand can be effective at a low tastand concentration when compared. to the eatable with the undesirable taste.
- This distinction is not a minor teaching as in practical terms it would be impossible to add more of the debittering material than the bitter materials. If the Tamura paper's lower level of proposed use for taurine (0.5 equivalents of taurine) is added to a one percent (1%) KCl solution, the resultant solution has a pronounced off-taste which was not present when only 0.03 equivalents (0.5% by weight relative to the KCl) was used.
- the L-aspartyl-L-phenylalanine that is added as a tastand to the material sweetened with the L-aspartyl-L- phenylalanine methyl ester is in addition to the amount of L-aspartyl-L-phenylalanine that may or may not be present from the breakdown product of the L- aspartyl-L-phenylalanine methyl ester (Aspartame ® ) or as a manufacturing impurity.
- the use of L-aspartyl-L- phenylalanine as a tastand is an unanticipated result that was not previously known or contemplated.
- L- aspartyl-L-phenylalanine is one of the breakdown products of L-aspartyl-L-phenylalanine methyl ester (Aspartame ® )
- the breakdown of the L-aspartyl-L-phenylalanine methyl ester (Aspartame ® ) has not been considered a desirable occurrence.
- Both the manufacturers and users of the L- aspartyl-L-phenylalanine methyl ester (Aspartame ® ) go to great lengths to prevent this degradation. They attempt to do this by adjusting the formulations of the products in which the material is used.
- the undesirable breakdown of the product can be slowed down by selling the material in a dry state, as well as by the purification of the material.
- L- aspartyl-L-phenylalanine is typically present in an amount less than one percent ( ⁇ 1%) of the L-aspartyl-L-phenylalanine methyl ester.
- the above example of the addition of five (5) to seven and one half (71 ⁇ 2) mg of L-aspartyl-L-phenylalanine would be about four percent (4%) of the L-aspartyl- phenylalanine methyl ester that has been used to
- Examples of the products that could be found from the breakdown of the L-aspartyl-L-phenylalanine methyl ester in the soda are ⁇ -L-aspartyl-L-phenylalanine, ⁇ -L- aspartyl-L-phenylalanine, methanol, L-aspartyl-L- phenylalanine diketopiperazine, L-phenylalanine, L-aspartic acid, L-phenylalanine methyl ester and ⁇ -L-aspartyl-L- phenylalanine methyl ester.
- the ratio of these and other possible breakdown products will vary according to the conditions of storage (time and temperature) as well as the soda's specific composition its pH, etc.)
- the present invention teaches the use of the breakdown products, whether such breakdown occurs deliberately or accidently, of the L-aspartyl-L-phenylalanine methyl ester (Aspartame ® ) into one or more tastand(s).
- Another example of a breakdown product of the L-aspartyl-L-phenylalanine methyl ester (Aspartame ® ) that is a tastand is ⁇ -L-aspartyl-L- phenylalanine.
- soda is sweetened with both L-aspartyl-L- phenylalanine methyl ester (Aspartame ® ) and saccharin then two tastands may be needed to reduce or substantially eliminate the off-taste of the two high intensity
- sweeteners For example both taurine and L-aspartyl-L- phenylalanine could be used.
- the levels of the tastands that would be needed would depend on the relative levels of the high intensity sweeteners that were used in the soda.
- tastands Combination of tastands are sometimes preferred.
- a salt consisting of a ratio of eighty percent (80%) KCl and twenty percent (20%) NaCl with taurine at five percent (5%) relative to the KCl and three percent (3%) L-aspartyl-L-phenylalanine is sometimes preferred to a single tastand.
- Such single tastand could be for example taurine, L-aspartyl-L-phenylalanine or
- controls will be altered by the use of the blockers in the same randomized tasting. This "moving" of the controls will occur because the blockers are consumed before the eatables that do not contain the blockers. (If an eatable that was found to be bitter in a previously conducted taste test were presented to the panelist at or near the end of the tasting that contained a tastand, the typical result would be that the previously bitter food is no longer nearly as bitter.) In some tests conducted in a randomized manner, pure KCl foods, for example, which were earlier determined to be very bad, bitter and metallic, during the first round of testing, were then determined to be almost as good tasting as NaCl foods when tasted at or near the end of the tasting.
- gymnemic acid is not a tastand under the definition contained herein.
- sweet receptor and the bitter receptor as well as the other taste receptors may be in close proximity and/or related to one another and/or possibly one and the same. It is now known, for example, that if sweet molecules are altered slightly, particularly in their spatial arrangements and/or orientation and/or configuration of their chiral centers and/or their
- A. is a tastand will change said molecule into a molecule that is a more active tastand or less active tastand or not a tastand at all, or
- Such transformations in a molecule may change the molecule from any one of these (sweet, bitter or tasteless) to any of the following: sweet, bitter or tasteless.
- the perception of sweet and the perception of bitter may be associated with the same receptor, part of the same receptor, very closely spatially related receptors or separate receptors which act together to give the associated sweet or bitter taste response, and
- receptor site(s) or “receptor(s)”
- L- aspartyl-L-phenylalanine methyl ester (Aspartame ® ) is intensely sweet.
- L-aspartyl-L-phenylalanine methylamide is intensely bitter and L-aspartyl-L- phenylalanine free acid is tasteless.
- alkylamides are sweet and many of the corresponding L- amides are bitter.
- the molecule may inhibit or reduce the sweetness of substances, and in some instances it will also inhibit or reduce undesirable tastes; and/or
- the molecule may inhibit or reduce the bitterness of substances, and in some instances it will also inhibit or reduce other
- a sweet molecule can be spatially altered to become substantially tasteless, this molecule will likely be a tastand; and/or
- molecule could be linked with one or more similar or dissimilar tastand molecule (s).
- synergism of molecules in some cases may allow two or more molecules, that in and of themselves do not appear to be tastands, to act as a tastand when said molecules are used in a temporally appropriate manner.
- potassium chloride potassium glutamate, potassium benzoate, potassium nitrate, potassium nitrite, potassium sulfate, potassium sulfite, potassium baking powder and potassium baking soda (which probably become potassium chloride or other potassium salts after baking), aspirin, acetaminophen, antibiotics, codeine, caffeine, unsweetened chocolate, other medicaments or other undesirable taste(s) of the eatable.
- tastands have also been found to enhance salt taste.
- tastands can be used in conjunction with mixtures of substances with undesirable tastes such as, for example, potassium chloride and/or sodium chloride and/or ammonium chloride to both reduce the undesirable taste(s) and to enhance the salt taste of the sodium and/or
- a smoothing effect can be achieved when a tastand is added to plain unflavored, unsweetened yogurt which is normally considered tangy or acidic tasting.
- the tastands useful in the present invention are those compounds of the prior art which are tastands that are substantially tasteless. In many instances, substances of the prior art which could be tastands which are not
- tasteless can be rendered substantially tasteless by transformation(s).
- alkyl substituted alkyl, alkoxy, substituted alkoxy, aryl, substituted aryl, alkylene, substituted alkylene, aminoacyl, substituted aminoacyl, aryloxy, substituted aryloxy, hydroxy, nitro, amino,
- arylacyl substituted arylacyl, trifluoroacetyl, benzoyl, substituted benzoyl, alkylamino, substituted alkylamino, dialkylamino, substituted dialkylamino, trialkylamino, substituted trialkylamino, carbonates, substituted carbonates, alkylcarbonates, substituted alkylcarbonates , arylcarbonates , substituted
- arylcarbonates acylamino, substituted acylamino, guanidino, substituted guanidino, alkylguanidino, substituted alkylguanidino, acylguanidino, substituted acylguanidino, arylguanidino, substituted
- alkyurethanes arylurethanes, substituted arylurethanes, ureas, substituted ureas, mono- or di- or tri- substituted ureas, alkylureas, substituted alkylureas, an O, S or N glycoside, or a
- glycoside is a monosaccharide, a disaccharide, a trisaccharide, an oligosaccharide, a substituted mono-, di-, tri-, or oligosaccharide
- CHO substituted CHO, COCH-, substituted COCH 3 , CH 2 CHO, substituted CH 2 CHO, COOH, CH 2 COOH, substituted CH 2 COOH, COOCH 3 , substituted COOCH 3 , OCOCH 3 , substituted OCOCH 3 , CONH 2 , substituted CONH 2 , NHCHO, substituted SCH 3 , substituted SCH 3 , SCH 2 CH 3 , substituted SCH 2 CH 3 , CH 2 SCH 3 , substituted CH 2 SCH 3 , SO 3 H, SO 2 NH 2 , substituted SO 2 NH 2 , SO 2 CH 3 , substituted SO 2 CH 3 , CH 2 SO 3 H, substituted CH 2 SO 3 H, cycloalky
- carboxamides substituted di-alkyl carboxamides, and/or two substituents together represent an
- any H on N, S, or O may be substituted with one of the substituents of Group 2, and combinations of any and/or all of the foregoing, and physiologically accept .ble salts of any and/or all of the foregoing.
- alkyl substituted alkyl, dialkyl, substituted dialkyl, aralkyl, substituted aralkyl, aryl,
- alkylaminocarbonyl substituted alkylaminocarbonyl, arylaminocarbonyl, substituted arylaminocarbonyl, amidines, substituted amidines, alkylamidines, substituted alkylamidines, arylamidines, substituted arylamidines, a monosaccharide, substituted a
- substituted phosphorylated saccharides arylacyl, substituted arylacyl, alkylene, substituted alkylene, heterocyclic, substituted heterocyclic, polycyclic, substituted polycyclic, cyano, nitro, any H on N, S, or O, may be substituted with one of the above substituents,
- substituted indicates that the molecule may have any hydrogen atom replaced or “substituted” by any of the substituents of
- R represents H or a lower alkyl (e.g. of C 1 -C 3 alkyl); the substituents R', which may be the same or
- X + represents H + or a physiologically acceptable cation, and physiologically acceptable salts of any and/or all of the foregoing.
- B-1 represents the general class of compounds having the structure:
- R 7 may be selected from the group consisting of hydrogen and C 1 -C 3 alkyl
- R 8 may be selected from the group consisting of hydrogen and C 1 -C 3 alkyl and wherein R 1 , is the group, (as used herein and the appended claims the structure shall be referred to as B-2):
- R 2 , R 3 , R 4 , R 5 and R 6 are independently selected from the substituents of Group 1, in any combination, and physiologically acceptable salts of any and/or all of the foregoing.
- Illustrative members of particular interest in this class include:
- C-1 represents the general class of compounds having the structure:
- R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are individually represented by one of the substituents of Group 1, in any combination,
- Illustrative members of particular interest in this class include:
- R 1 OC 2 H 5
- R 4 NH-CO-NH 2
- R 1 CH 3
- R 2 NH 2
- R 6 NO 2
- D-1 As used herein and the appended claims the following molecule shall be referred to as D-1 and said molecule represents the general class of compounds having the structure:
- n and k independently may be 0, 1 or 2; Y (which may be the same or different) may be N
- Q may be represented by one of the substituents of Group 3; p and q are 1 when Y is O and p and q may be
- R (which may be the same or different when p>1) and R' (which may be the same or different when q>1) are represented by one of the substituents of Group 2 or one of the following three structures (as used herein and the appended claims the structures shall be referred to as D-2) in any combination and the appropriate stereochemistry:
- Z and Z' are the same or different and are represented by OH, -O-X + OR", NH 2 , NHR", N(R") 2 ,;
- R" may be alkyl, branched alkyl, aryl, aralkyl, alkaryl, cycloalkyl, substituted alkyl, substituted cycloalkyl substituted aryl, substituted aralkyl, substituted alkaryl, and R'" may be alkyl, branched alkyl, aryl, aralkyl, alkaryl, cycloalkyl, substituted alkyl, substituted cycloalkyl, substituted aryl, substituted aralkyl, substituted alkaryl, or an amino acid side chain (e.g. one of the 20 common amino acids),
- X + may be H + or a physiologically acceptable cation,
- E-1 represents the general class of compounds having the structure:
- R', R", R"', R 6 are each independently
- R 4 's and R 5 's which may be the same or different are each independently represented by one of the substituents of Group 3; n may be 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10; Z may be C, S, P or B, q is an integer from 2 to 3 and r is an integer from 1 to 3, when Z is C, q is 2; when Z is S, P or B, q may be 2 or 3; when Z is C or S, r is 1; when Z is P or B, r is 2,
- substituents of Group 3 are 1 when Y is O and p and q may be independently 1 or 2 when Y is S and p and q may be independently 2 or 3 when Y is N; R (which may be the same or different when p>1) and R' (which may be the same or different when q>1) are represented by one of the substituents of Group 2 or one of the following three structures (as used herein and the appended claims the structures shall be referred to as F-2) in any combination and the appropriate stereochemistry:
- Z and Z' are the same or different and are represented by OH, -O-X + , OR", NH 2 , NHR" , N(R") 2 ,; R" is alkyl, branched alkyl, aryl, aralkyl, alkaryl, cycloalkyl, substituted alkyl, substituted cycloalkyl substituted aryl, substituted aralkyl, substituted alkaryl, and R"' is alkyl, branched alkyl, aryl, aralkyl, alkaryl, cycloalkyl, substituted alkyl, substituted cycloalkyl, substituted aryl, substituted aralkyl, substituted alkaryl, or an amino acid side chain (e.g. one of the 20 common amino acids).
- X + may be H + or a physiologically acceptable cation
- G-1 represents the general class of compounds having the structure:
- R 1 may each be represented by one of the substituents of Group 1, in any combination, and R 2 may be represented by one of the substituents of Group 2,
- H-1 H-1
- said molecule represents the general class of compounds having the structure:
- R 1 is 5-tetrazol
- p may be 1, 2, 3, or 4
- R 2 which may be the same or
- R 3 is represented by one of the substituents of Group 2, and physiologically acceptable salts of any and/or all of the foregoing.
- I-1 represents the general class of compounds having the structure:
- J-1 a compound having the structure:
- R 1 is represented by one of the substituents of Group 2
- R 2 and R 3 which may be the same or different, may be represented by one of the
- R 2 p-cyanophenylcarbamoyl
- K As used herein and the appended claims the following molecule shall be referred to as K-1 and said molecule represents the general class of compounds having the structure:
- R 1 is represented by one of the substituents of Group 1, in any combination, and R 1 is represented by one of the substituents of Group 2, wherein R 1 and R 2 may be present, in any combination,
- L-1 L-1
- said molecule represents the general class of compounds having the structure:
- R, R 1 and R 2 which may be the same or
- R 1 H
- R 2 t-butyl
- Z S
- R 1 p-cyanophenylcarbamoyl
- M-1 As used herein and the appended claims the following molecule shall be referred to as M-1 and said molecule represents the general class of compounds having the structure:
- R, R 1 and R 2 which may be the same or different, are each represented by one of the substituents of Group 1, in any combination and R 3 is represented by one of the substituents of Group 2, wherein R, R 1 , R 2 and R 3 may be present in any combination,
- R 2 H
- N-1 N-1-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N
- N-2 Illustrative of compounds of particular interest in this class is the following molecule which as used herein and the appended claims shall be referred to as N-2:
- This class includes but is not limited to:
- the nitrogen atoms of these compounds may be
- P As used herein and the appended claims the following molecule shall be referred to as P-1 and said molecule represents the general class of compounds having the generalized structure:
- substituents R and R 3 which may be the same or different, are each represented by one of the substituents of Group 1, in any combination;
- R 1 and R 2 which may be the same or different, may each be represented by one of the substituents of Group 2, in any combination, and A may be C, S, N, or O and when A is C, substitution on this carbon may be made with one or more of the substituents of Group 1, in any combination
- Q-1 As used herein and the appended claims the following molecule shall be referred to as Q-1 and said molecule represents the general class of compounds having the generalized structure:
- R 1 , R 2 , R 3 , and R 5 which may be the same or different, are each represented by one of the substituents of Group 1, in any combination; R 4 and R 6 , which may be the same or different, are
- this class is intended to include any oxidation state of the ring system, as for example, hydrogenation of one or more of the double bonds.
- R The class of compounds commonly known as natural products. This class includes but is not limited to:
- alkaloids terpines, monoterpines, diterpines,
- triterpines triterpines, sesqueterpines, flavanoides, chalcones, dihydrochalcones, humulones, lemonoids, saponins, coumarins, isocoumarins, sinapines, steroids,
- R-1 As used herein and the appended claims the following molecule shall be referred to as R-1, and said molecule exemplifies the general class of compounds having, but not limited to the following structure:
- R-2 As used herein and the appended claims the following molecule shall be referred to as R-2 and said molecule represents the general class of compounds having, but not limited to the following structure:
- R-3 As used herein and the appended claims the following molecule shall be referred to as R-3 and said molecule represents the general class of compounds having, but not limited to the following structure:
- R-4 As used herein and the appended claims the following molecule shall be referred to as R-4 and said molecule represents the general class of compounds having, but not limited to the following structure:
- R-6 As used herein and the appended claims the following molecule shall be referred to as R-6 and said molecule represents the general class of compounds having, but not limited to the following structure:
- R-7 As used herein and the appended claims the following molecule shall be referred to as R-7 and said molecule represents the general class of compounds having, but not limited to the following structure:
- R-8 As used herein and the appended claims the following molecule shall be referred to as R-8 and said molecule represents the general class of compounds having, but not limited to the following structure:
- R-13 As used herein and the appended claims the following molecule shall be referred to as R-13 and said molecule represents the general class of compounds having, but not limited to the following structure:
- R-16 As used herein and the appended claims the following molecule shall be referred to as R-16 and said molecule represents the general class of compounds having, but not limited to the following structure:
- R-20 As used herein and the appended claims the following molecule shall be referred to as R-20 and said molecule represents the general class of compounds having, but not limited to the following structure:
- R-23 As used herein and the appended claims the following molecule shall be referred to as R-23 and said molecule represents the general class of compounds having, but not limited to the following structure:
- R-26 As used herein and the appended claims the following molecule shall be referred to as R-26 and said molecule represents the general class of compounds having, but not limited to the following structure:
- R-27 As used herein and the appended claims the following molecule shall be referred to as R-27 and said molecule represents the general class of compounds having, but not limited to the following structure:
- R-28 As used herein and the appended claims the following molecule shall be referred to as R-28 and said molecule represents the general class of compounds having, but not limited to the following structure:
- R-29 As used herein and the appended claims the following molecule shall be referred to as R-29 and said molecule represents the general class of compounds having, but not limited to the following structure:
- R-31 As used herein and the appended claims the following molecule shall be referred to as R-31 and said molecule represents the general class of compounds having, but not limited to the following structure:
- R-33 As used herein and the appended claims the following molecule shall be referred to as R-33 and said molecule represents the general class of compounds having, but not limited to the following structure:
- R-34 As used herein and the appended claims the following molecule shall be referred to as R-34 and said molecule represents the general class of compounds having, but not limited to the following structure:
- R-35 As used herein and the appended claims the following molecule shall be referred to as R-35 and said molecule represents the general class of compounds having, but not limited to the following structure:
- R-36 As used herein and the appended claims the following molecule shall be referred to as R-36 and said molecule represents the general class of compounds having, but not
- examples may be substituted with a variety of aliphatic, alicyclic, aromatic groups, hydroxy, amino, or other substituents of group 1 or 3, as defined above, and
- hydroxyl, amino or thio groups may be substituted with one of the substituents of group 2, as defined above.
- the stereochemical relationships of the substituents may be cis or trans, and chiral centers may be of R or S
- nitrogen or oxygen atoms may be substituted with group 2, substituents or mono or polysaccharides including but not restricted to those indicated in the above examples.
- R 1 ⁇ -D-glc
- R 2 ⁇ -L-rha-3-Me
- S-1 The class of compounds having the structure, or structures closely related to the following molecule which as used herein and the appended claims shall be referred to as S-1:
- R 1 , R 2 , R 3 , and R 4 which may be the same or different are each designated by one of the
- R 5 is represented by one of the substituents of Group 2
- R 6 is represented by one of the substituents of Group 3, wherein R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 , may be present in any combination.
- T-1 The class of compounds having the structure (or structures closely related to) which as used herein and the appended claims shall be referred to as T-1:
- R 1 which may be the same or different, are each represented by one of the substituents of Group 1 in any combination;
- R 2 and R 3 which may be the same or different, are each
- each R 4 and R 5 may be independently represented by one of the substituents of Group 3 and wherein R 1 , R 2 R 3 R 4 , and R 5 may be present in any combination; n may be
- Z may be an element selected from the group consisting of carbon, sulfur, boron, or phosphorus; q is an integer from 2 to 3 and r is an integer from 1 to 3, when Z is C, q is 2; when Z is S, P or B, q may be 2 or 3; when Z is C or S, r is 1;
- R 1 p-cyano
- R 1 p-nitro;
- R 1 p-cyano
- R 1 p-nitro;
- A may be O(oxygen), S (sulfur), or C(carbon), and when A is C, n is l and when A may be O or S, n is zero;
- R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 and R 12 which may be the same or different, and which may be present in any combination, may each be represented by one of the following: one of the substituents of
- membered (pyranose) rings of this class may isomerize to five membered (furanose) rings as is well known for many sugars.
- V The class of compounds having the structure (or structures closely related to) which as used herein and the appended claims shall be referred to as V-1:
- X + may be H + or a physiologically acceptable cation, preferably an alkali metal, alkaline earth metal or ammonium cation,
- R (which may be the same or different when p>1) and R' (which may be the same or different when q>1) are represented by one of the substituents of Group 2 or one of the following three structures (as used herein and the appended claims the structures shall be referred to as W-2) in any combination and the appropriate stereochemistry:
- chelators are molecules capable of chelating with, binding with, complexing with or coordinating with metal ions. Included in this class are the physiologically acceptable salts of any and/or all of the foregoing.
- Ethylenediaminetetraacetic acid EDTA
- individual tastand as described in Classes A-X may be enhanced by one surfactant while the same surfactant may lessen the effectiveness of other tastands or not affect that particular tastand at all.
- Surfactants can increase the effectiveness of some tastands while the same surfactant may lessen the effectiveness of other tastands or not affect that particular tastand at all. Surfactants may affect each tastand differently. The surfactant that affects one particular tastand in a
- positive, negative or neutral sense may affect another tastand differently (i.e. a positive, negative or neutral sense and not necessarily in the same way).
- Kier J. Pharm. Sci. 1972, 61, 1394; which is hereby incorporated by reference
- Kier expanded on the model of Shallenberger and Acree and proposed the existence of a third binding site which involved a hydrophobic
- this group is a -CN or a -NO 2 group.
- the C ⁇ -C ⁇ bond of the aspartyl residue possesses a staggered conformation with the carboxyl moiety and the amino group in the gauche position and the sp 2 plane of the terminal aspartyl carboxylate carbon atom and the C ⁇ -C ⁇ bond coplanar. These conditions are conformationally favorable for the formation of the zwitterionic aspartyl ring.
- Crystallization was achieved in the tetragonal space group P4 1 with four L-aspartyl-L-phenylalanine methyl ester molecules and one water molecule per unit cell.
- the molecule shows an extended conformation with trans peptide bonds.
- the phenyl ring is perpendicular to the peptide backbone and not coplanar with the zwitterionic ring of aspartic acid as would be predicted for a sweet dipeptide.
- This twisting of the phenyl ring is due to packing forces within the crystal structure which result in stacking of adjacent L-aspartyl-L-phenylalanine methyl ester molecules into stable columnar structures.
- the isolated molecule from the crystal structure can be rotated 40° about the ⁇ (Phe) bond, to achieve an isoenergetic
- FIG. 3 depicts L-aspartyl-L-phenylalanine methyl ester in the L "shape" required for sweet taste in the Goodman model superimposed in the 8- centered Tinti and Nofre model.
- Belitz (ACS, Food Taste Chemistry, 1979, 93-131; which is hereby incorporated by reference) describes minimum requirements for bitter taste perception as a molecule possessing an AH group and a hydrophobic moiety. Using the model ascribed to Goodman above the hydrophobic moiety of Belitz would be in the -z (or bitter taste) region
- decreasing of the distance between the various hydrogen bonding and hydrophobic interaction sites may result in a change in binding conformation and/or structure in a manner which prevents substantial interaction with the sweet taste (G or X) zone or substantial interaction with the bitter taste (-z) zone, thus, generating a substantially tasteless molecule.
- said tastand may be capable of competing favorably against one class of compounds, say for instance sweeteners, and unfavorably against other classes of compounds such as bitter
- bitter taste It has also been reported and we have found that there are at least two types of bitter taste.
- a tastand may compete favorable against organic bitter taste, perhaps even favorably against sweet taste as well, and unfavorably against potassium ion, depending on the sites of interaction. Conversely the tastand may compete
- L-aspartyl-L- phenylalanine methyl ester is approximately 200 times sweeter than sucrose.
- L-Aspartyl-L-phenylalanine methyl ester can be transformed to a bitter compound by changing the L-phenylalanine methyl ester to D-phenylalanine methyl ester (which places the phenyl ring in the -z (bitter taste) zone.
- L-Aspartyl-L-phenylalanine methyl ester can also be transformed to a tasteless compound by changing the methyl ester to a carboxylic acid.
- L-Aspartyl-L- phenylalanine (L-aspartyl-L-phenylalanine methyl ester minus the methyl ester) is tasteless and has been shown to effectively block the bitter taste of potassium ion.
- L- Aspartyl-L-phenylalanine has minimal effect on the sweet taste of L-aspartyl-L-phenylalanine methyl ester but does block the sweet taste of sucrose at very high
- N-(p- Cyanophenylcarbamoyl)-L-aspartyl-L-phenylalanine methyl ester as described by Tinti and Nofre is 14,000 times sweeter than sucrose.
- N-(p- Cyanophenylcarbamoyl)-aminomethanesulfonate which possesses a D and B site, and is essentially tasteless inhibits organic bitter taste (caffeine) and sweet taste, but not the bitter taste associated with potassium chloride.
- Taurine and ⁇ -alanine which both possess an AH, B array are both example of tastands.
- tasteless or nearly tasteless compounds which can be generated by transformation of a sweet or bitter compound in a manner that eliminates hydrophobic interactions in the -z or X(G) areas (as defined by Goodman or Tinti and Nofre) of the taste receptor(s).
- Such tastands are capable of blocking or inhibiting any one or any combination of the three tastes; sweet, organic bitter or inorganic bitter.
- a molecule need only interact with one of the hydrogen bonding sites described above and have little or no
- hydrophobic interactions in the X (sweet taste) region and which also do not allow hydrophobic interactions in the -z (bitter taste) zone are tastands as defined herein.
- conformation and/or structure prevents any hydrophobic interactions with the G (sweet taste) region and which also do not allow hydrophobic interactions in the -z (bitter taste) zone which is developed when the AH, B, D, G system of Tinti and Nofre is superimposed into the AH, B, X system of Goodman ( Figure 4), are tastands.
- FIG. 3 The Goodman model for the sweet taste with L- aspartyl-L-phenylalanine methyl ester superimposed.
- the ⁇ bond shown by the arrow, has been rotated 40° from the X- ray diffraction structure.
- the hydrogen atoms have been added, with the standard bond lengths and angles.
- the AH-B and X groups of the molecule are illustrated according to the Shallenberger-Kier suggestions.
- the present invention contemplates use of the tastands in either the racemate or as the individual optical isomers. It is likely that one or the other of the optical isomers of the racemic tastands possess the greater, if not all, of the blocking or tastand activity. For example, it has been found that the (-) isomer of 2-(4-methoxyphenoxy) propionic acid possesses the majority of the activity that reduces undesirable tastes. The use of the most active isomer alone is advantageous in that far less tastand is needed to gain the desired
- tastands described above and in particular (-)-2-(4-methoxyphenoxy)propionic acid in addition to inhibiting bitter taste also enhances the salty taste of sodium containing compounds, if employed in sufficient concentrations.
- the present invention contemplates the preparation of eatables containing, for example, low sodium chloride and the tastands in an amount sufficient to enhance the salty taste of sodium chloride.
- the present invention contemplates the preparation of eatables comprised of a mixture of
- substances having an undesirable taste such as potassium chloride, magnesium chloride with sodium chloride and/or ammonium chloride in conjunction with the tastands referred to herein in an amount that both reduces the undesirable taste(s) and enhances the salty taste of the sodium
- Preferred eatable admixture products of the invention comprise from slightly more than 0 up to about 300% by weight of substances with undesirable tastes such as, for example, potassium chloride and magnesium chloride and 0 to 50% by weight sodium chloride in combination with effective concentrations of a tastand(s), typically 0.001% to about 50% preferable 0.1% to about 5%.
- the present invention contemplates the preparation of eatables such as breads, biscuits, pancakes, cakes, pretzels, snack foods, baked goods etc. prepared using for example potassium bicarbonate or potassium carbonate in place of the sodium salts as leavening agents in conjunction with a tastand in an amount sufficient to eliminate the undesirable taste associated with potassium ion or other tastes.
- the tastand is typically present in an amount ranging from about 0.001% to about 50% by weight, preferably about 0.1% to about 10% by weight, of the material with the undesirable taste.
- the present invention also contemplates the preparation of preservatives for eatables comprised of the potassium salts of benzoate, nitrate, nitrite, sulfate and sulfite and so on, in
- the tastand is usually about 0.001% to about 10%, preferably about 0.1% to about 5%, by weight of the tastand.
- the present invention also contemplates the use of potassium salts of flavoring agents (such as for example glutamate) in place of sodium salts. Consequently
- the tastand can be present from about 0.0000001% to about 300%, preferably from about 0.1% to about 5%, by weight of the material with the undesirable taste.
- the present invention also contemplates the
- tastand preparation of medicaments such as aspirin, acetaminophen, ibuprofen, codeine, antibiotics, etc. in conjunction with a tastand(s) in sufficient concentration to remove or reduce the undesirable taste (s) of these materials.
- the tastand is usually 0.001% to about 50% by weight, preferably from about 0.5% to about 5% by weight of the material with the undesirable taste.
- the present invention also contemplates the preparation of eatables which have inherently
- the tastand is usually about 0.001% to about 50% by weight, preferably about 0.2% to about 5%, by weight of the
- sweeteners such as sweeteners, spices, and/or other flavorings.
- concentration of tastand employed to reduce the undesirable taste(s) in any given instance will vary depending principally on the particular tastand selected, the particular substance or substances with the undesirable taste(s), the extent of the reduction of the undesirable taste(s) desired as well as the other tastes and flavors present in the mixture. In most instances, concentrations of about 0.001 to by weight, preferably about 0.05 to 5% of tastand to the material with the undesirable taste are satisfactory.
- the tastand when the tastand is selected for use with an admixture of sodium chloride and an undesirable tasting substance such as potassium chloride and/or magnesium chloride, it will generally be necessary to employ at least 0.2% by weight up to 10% by weight of the tastand based on the weight of the salt(s) to obtain both the reduction of the undesirable taste(s) and salty taste enhancement.
- an undesirable tasting substance such as potassium chloride and/or magnesium chloride
- the eatables to which the tastands of the invention can be added are without limitation and include both foodstuff and eatables having essentially no food value such as pharmaceuticals, medicaments and other eatables. Therefore, the tastands of the present invention are effective for use with all substances which have an
- undesirable taste(s) Illustrative of substances with undesirable taste(s) with which the taste modifiers of the invention can be used are potassium chloride, ammonium chloride, sodium chloride, magnesium chloride, halide salts, naringin, caffeine, urea, magnesium sulfate,
- saccharin acetosulfames, aspirin, potassium benzoate, potassium bicarbonate, potassium carbonate, potassium nitrate, potassium nitrite, potassium sulfate, potassium sulfite, potassium glutamate, food preservatives in their physiologically acceptable salts, ibuprofen, acetaminophen, antibiotics, codeine, cognac, unsweetened chocolate, cocoa beans, yogurt, preservatives, flavor enhancers, dietary supplements, gelling agents, Ph control agents, nutrients, processing aids, bodying agents, dispersing agents,
- additives tableting aids, lye peeling agents, washing water agents, oxidizers, antioxidants, enzymes, extenders, fungicides, cake mixes, coffee, tea, dry mixes, non-dairy creamers, salts, animal glue adjuvant, cheese, nuts, meat and meat products, poultry and poultry product, pork and pork products, fish and fish products, vegetable and vegetable products, fruit and fruit products, smoked products such as meat, cheese fish, poultry, and
- the taste of lithium chloride was greatly improved by the addition of 1% by weight (-)-2-(4- methoxyphenoxy)propionic acid sodium salt .
- the saltiness was substantially increased.
- Potassium benzoate containing 0.5% by weight (-)-2-(4- methoxyphenoxy)propionic acid sodium salt was added to foodstuffs in place of sodium benzoate. There was no detectable difference in the taste of the foodstuffs.
- Potassium nitrate and potassium nitrite containing 0.5% (-)-2-(4-methoxyphenoxy)propionic acid sodium salt were added to foodstuffs in place of the sodium salts. There was no detectable difference in the taste.
- Potassium bicarbonate/carbonate mixture containing 0.5% by weight (-)-2-(4-methoxyphenoxy) propionic acid sodium salt was used in place of baking powder for the preparation of pancakes. Essentially no bitterness was detected.
Abstract
Description
Claims
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SK620-94A SK62094A3 (en) | 1991-11-27 | 1992-11-24 | Specific eatable taste modifiers |
AU32250/93A AU675778B2 (en) | 1991-11-27 | 1992-11-24 | Specific eatable taste modifiers |
EP93900657A EP0661932A4 (en) | 1991-11-27 | 1992-11-24 | Specific eatable taste modifiers. |
US08/244,306 US5631038A (en) | 1990-06-01 | 1992-11-24 | Specific eatable taste modifiers |
JP5510237A JPH07504810A (en) | 1991-11-27 | 1992-11-24 | Specific edible taste modifier |
NO941972A NO941972L (en) | 1991-11-27 | 1994-05-26 | Specific edible flavor modifiers |
FI942463A FI942463A (en) | 1991-11-27 | 1994-05-26 | Specific flavor modifiers for edible products |
BG98818A BG98818A (en) | 1991-11-27 | 1994-05-31 | Edible compounds, taste modifiers |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79920791A | 1991-11-27 | 1991-11-27 | |
US799,207 | 1991-11-27 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US6753793A Continuation-In-Part | 1990-06-01 | 1993-05-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1993010677A1 true WO1993010677A1 (en) | 1993-06-10 |
Family
ID=25175300
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1992/010179 WO1993010677A1 (en) | 1990-06-01 | 1992-11-24 | Specific eatable taste modifiers |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0661932A4 (en) |
JP (1) | JPH07504810A (en) |
AU (1) | AU675778B2 (en) |
BG (1) | BG98818A (en) |
CA (1) | CA2117284A1 (en) |
CZ (1) | CZ129094A3 (en) |
FI (1) | FI942463A (en) |
HU (1) | HUT68764A (en) |
NO (1) | NO941972L (en) |
SK (1) | SK62094A3 (en) |
WO (1) | WO1993010677A1 (en) |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995004476A1 (en) * | 1993-08-05 | 1995-02-16 | San-Ei Gen F.F.I., Inc. | Method of suppressing sweetness |
WO1995004479A1 (en) * | 1993-08-05 | 1995-02-16 | San-Ei Gen F.F.I., Inc. | Method of increasing pungency |
WO1995004477A1 (en) * | 1993-08-05 | 1995-02-16 | San-Ei Gen F.F.I., Inc. | Method of increasing sourness |
WO1995004478A1 (en) * | 1993-08-05 | 1995-02-16 | San-Ei Gen F.F.I., Inc. | Method of increasing bitterness and/or astringency |
US5766622A (en) * | 1996-08-14 | 1998-06-16 | The Procter & Gamble Company | Inhibiting undesirable taste in oral compositions |
WO2000001253A1 (en) * | 1998-07-07 | 2000-01-13 | Mcneil Specialty Products Company, Division Of Mcneil-Ppc, Inc. | Method of improving sweetness delivery of sucralose |
WO2000047045A1 (en) * | 1999-02-13 | 2000-08-17 | Zylepsis Limited | Preservative compounds and compositions |
JP2001233894A (en) * | 2000-02-21 | 2001-08-28 | Toyo Suisan Kaisha Ltd | Novel terpenoids and medicines utilizing the biological activity of these compounds |
EP1706412A1 (en) * | 2003-12-30 | 2006-10-04 | SK Chemicals, Co., Ltd. | Novel pyridine derivatives, a process for their preparation and a pharmaceutical composition containing the same |
FR2883873A1 (en) * | 2005-03-31 | 2006-10-06 | Pharmamens Sarl | AGE INHIBITORS |
WO2007055426A1 (en) | 2005-11-14 | 2007-05-18 | Kao Corporation | Liquid seasoning |
US7803982B2 (en) | 2001-04-20 | 2010-09-28 | The Mount Sinai School Of Medicine Of New York University | T1R3 transgenic animals, cells and related methods |
EP2353403A1 (en) | 2010-02-01 | 2011-08-10 | Symrise AG | Use of 1-(2,4-dihydroxy-phenyl)-3-(3-hydroxy-4-methoxy-phenyl)-propan-1-on |
US8017168B2 (en) | 2006-11-02 | 2011-09-13 | The Coca-Cola Company | High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith |
JPWO2010113925A1 (en) * | 2009-03-30 | 2012-10-11 | 株式会社 資生堂 | UV damage reducing composition |
US8399034B2 (en) | 2008-01-31 | 2013-03-19 | Kao Corporation | Miso |
CN103288673A (en) * | 2013-05-28 | 2013-09-11 | 广东药学院 | Platinum ligand and coordination compound thereof |
RU2535099C2 (en) * | 2009-09-29 | 2014-12-10 | Сисеидо Компани, Лтд. | Antioxidant composition |
US9035085B2 (en) | 2004-05-14 | 2015-05-19 | Emisphere Technologies, Inc. | Aryl ketone compounds and compositions for delivering active agents |
US9101160B2 (en) | 2005-11-23 | 2015-08-11 | The Coca-Cola Company | Condiments with high-potency sweetener |
US9408407B2 (en) | 2010-04-15 | 2016-08-09 | Chromocell Corporation | Compounds, compositions, and methods for reducing or eliminating bitter taste |
US9706790B2 (en) | 2011-10-20 | 2017-07-18 | Chromocell Corporation | Compounds, compositions, and methods for reducing or eliminating bitter taste |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7229658B1 (en) * | 1998-10-28 | 2007-06-12 | San-Ei Gen F.F.I., Inc | Compositions containing sucralose and application thereof |
EP1402892A4 (en) * | 2001-06-11 | 2006-11-08 | Kyowa Hakko Kogyo Kk | Antiinflammatoric and antitussive compositions |
JP4531494B2 (en) * | 2004-09-01 | 2010-08-25 | 三栄源エフ・エフ・アイ株式会社 | Peptide-containing beverage |
JP5066742B2 (en) * | 2007-09-28 | 2012-11-07 | 株式会社林原 | Taste and / or umami enhancement method from salt of food and drink |
WO2010026003A1 (en) * | 2008-09-05 | 2010-03-11 | Unilever Plc | Flavan-3-ol containing foodstuffs |
MX2012011996A (en) * | 2010-04-15 | 2013-11-27 | Chromocell Corp | Compounds, compositions, and methods for reducing or eliminating bitter taste. |
JP6021166B2 (en) * | 2010-12-24 | 2016-11-09 | 三井農林株式会社 | Antihypertensive |
WO2013111716A1 (en) * | 2012-01-27 | 2013-08-01 | キリンホールディングス株式会社 | Sweetener composition and method for improving sweetness of sweet substance |
SG11201405340XA (en) | 2012-03-30 | 2014-10-30 | Givaudan Sa | N-acylated methionine derivatives as food flavouring compounds |
CN104302191A (en) | 2012-03-30 | 2015-01-21 | 奇华顿股份有限公司 | N-acyl-amino acid derivatives for improvement of the flavour profile edible|compositions |
EP2830440B1 (en) | 2012-03-30 | 2019-03-20 | Givaudan SA | N-acyl-aminocyclopropyl carboxylic acids as food flavouring compounds |
BR112014023448B1 (en) | 2012-03-30 | 2021-06-22 | Givaudan Sa | EDIBLE OR DRINK COMPOSITION INCLUDING N-ACYL DERIVATIVES RANGE AMINO-BUTYRIC ACID AND STANDARD SOLUTION |
KR102045590B1 (en) | 2012-03-30 | 2019-11-15 | 지보당 에스아 | N-acylated 1-aminocycloalkyl carboxylic acids as food flavouring compounds |
JP6209588B2 (en) | 2012-03-30 | 2017-10-04 | ジボダン エス エー | N-acylproline derivatives as food flavoring compounds |
WO2013149031A2 (en) | 2012-03-30 | 2013-10-03 | Givaudan S.A. | Powder flavour composition |
JP6038483B2 (en) * | 2012-05-01 | 2016-12-07 | Mcフードスペシャリティーズ株式会社 | sweet sake |
JP6058280B2 (en) * | 2012-05-01 | 2017-01-11 | Mcフードスペシャリティーズ株式会社 | Seasoning containing salt and alcohol |
EP3057446B1 (en) | 2013-10-02 | 2017-12-06 | Givaudan S.A. | Organic compounds having taste-modifying properties |
CN105592720B (en) | 2013-10-02 | 2020-07-07 | 奇华顿股份有限公司 | Organic compounds with taste-improving properties |
US10674755B2 (en) | 2013-10-02 | 2020-06-09 | Givaudan S.A. | Organic Compounds |
WO2015050535A1 (en) | 2013-10-02 | 2015-04-09 | Givaudan S.A. | Organic compounds |
GB201317424D0 (en) | 2013-10-02 | 2013-11-13 | Givaudan Sa | Improvements in or relating to organic compounds |
CN105592719B (en) | 2013-10-02 | 2020-03-10 | 奇华顿股份有限公司 | Organic compounds |
US10834943B2 (en) | 2013-10-02 | 2020-11-17 | Givaudan S.A. | Organic compounds having taste-modifying properties |
US11122826B2 (en) | 2013-10-02 | 2021-09-21 | Givaudan Sa | Organic compounds |
WO2018093828A1 (en) * | 2016-11-16 | 2018-05-24 | International Flavors & Fragrances Inc. | Novel compositions for flavor enhancement |
Citations (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3860732A (en) * | 1970-03-30 | 1975-01-14 | Cumberland Packing Corp | Salt substitute |
US3903255A (en) * | 1971-05-17 | 1975-09-02 | Rohm & Haas | Effervescent potassium chloride tablet |
US3934047A (en) * | 1974-04-02 | 1976-01-20 | General Foods Corporation | Taste modifier for artificial sweeteners |
US4001455A (en) * | 1970-03-25 | 1977-01-04 | E. R. Squibb & Sons, Inc. | Sweetening compositions |
US4154862A (en) * | 1975-06-18 | 1979-05-15 | The United States Of America As Represented By The Secretary Of Agriculture | Method of reducing bitterness and off-after-taste |
US4183965A (en) * | 1978-12-26 | 1980-01-15 | International Flavors & Fragrances Inc. | 2- and 3-Cyclotetradecen-1-ones as bitterness depressants |
US4216244A (en) * | 1978-09-19 | 1980-08-05 | Allen Alfred E Jr | Low sodium salt seasoning |
US4219579A (en) * | 1979-01-25 | 1980-08-26 | Carl Piampiano | Means and method improving taste of saccharine sweetened food products |
US4544565A (en) * | 1984-03-29 | 1985-10-01 | General Foods Corporation | Foodstuffs containing sweetness inhibiting agents |
GB2157148A (en) * | 1984-04-12 | 1985-10-23 | Tate & Lyle Plc | Method of modifying taste |
US4567053A (en) * | 1983-04-12 | 1986-01-28 | Tate & Lyle Public Limited Company | Method of inhibiting sweetness |
US4642240A (en) * | 1982-09-30 | 1987-02-10 | General Foods Corporation | Foodstuffs containing 3-aminobenzesulfonic acid as a sweetener inhibitor |
US4871570A (en) * | 1983-03-22 | 1989-10-03 | General Foods Corp. | Foodstuffs containing hydrobenzene organic acids as sweetness modifying agents |
US4910031A (en) * | 1988-12-19 | 1990-03-20 | Frito-Lay, Inc. | Topped savory snack foods |
US4913921A (en) * | 1987-09-11 | 1990-04-03 | General Mills, Inc. | Food products containing fish oils stabilized with fructose |
US4917913A (en) * | 1989-09-29 | 1990-04-17 | International Flavors & Fragrances Inc. | Use of sclareolide in augmenting or enhancing the organoleptic properties of foodstuffs |
US4988532A (en) * | 1989-09-29 | 1991-01-29 | International Flavors & Fragrances Inc. | Use of sclareolide to debitter a coffee beverage |
US4994490A (en) * | 1989-04-03 | 1991-02-19 | The Nutrasweet Company | Novel N-(sulfomethyl)-N'-arylureas |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3649298A (en) * | 1970-04-16 | 1972-03-14 | Gen Mills Inc | Carbonation concentrates for beverages and process of producing carbonated beverages |
DE2211019C3 (en) * | 1972-03-08 | 1980-08-28 | Bayer Ag, 5090 Leverkusen | Oral penicillin flavor enhancing formulations |
CA1208966A (en) * | 1983-07-13 | 1986-08-05 | Ronald E. Barnett | Foodstuffs containing sweetness modifying agents |
US5094862A (en) * | 1989-08-25 | 1992-03-10 | Warner-Lambert Company | Salt substitute granule and method of making same |
US5021249A (en) * | 1989-11-09 | 1991-06-04 | Warner-Lambert Company | Method of making a savory flavor granule and a free flowing savory flavor granule |
US5232735A (en) * | 1990-06-01 | 1993-08-03 | Bioresearch, Inc. | Ingestibles containing substantially tasteless sweetness inhibitors as bitter taste reducers or substantially tasteless bitter inhibitors as sweet taste reducers |
-
1992
- 1992-11-24 EP EP93900657A patent/EP0661932A4/en not_active Withdrawn
- 1992-11-24 AU AU32250/93A patent/AU675778B2/en not_active Ceased
- 1992-11-24 WO PCT/US1992/010179 patent/WO1993010677A1/en not_active Application Discontinuation
- 1992-11-24 HU HU9401598A patent/HUT68764A/en unknown
- 1992-11-24 CA CA002117284A patent/CA2117284A1/en not_active Abandoned
- 1992-11-24 JP JP5510237A patent/JPH07504810A/en active Pending
- 1992-11-24 CZ CZ941290A patent/CZ129094A3/en unknown
- 1992-11-24 SK SK620-94A patent/SK62094A3/en unknown
-
1994
- 1994-05-26 FI FI942463A patent/FI942463A/en unknown
- 1994-05-26 NO NO941972A patent/NO941972L/en not_active Application Discontinuation
- 1994-05-31 BG BG98818A patent/BG98818A/en unknown
Patent Citations (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4001455A (en) * | 1970-03-25 | 1977-01-04 | E. R. Squibb & Sons, Inc. | Sweetening compositions |
US3860732A (en) * | 1970-03-30 | 1975-01-14 | Cumberland Packing Corp | Salt substitute |
US3903255A (en) * | 1971-05-17 | 1975-09-02 | Rohm & Haas | Effervescent potassium chloride tablet |
US3934047A (en) * | 1974-04-02 | 1976-01-20 | General Foods Corporation | Taste modifier for artificial sweeteners |
US4154862A (en) * | 1975-06-18 | 1979-05-15 | The United States Of America As Represented By The Secretary Of Agriculture | Method of reducing bitterness and off-after-taste |
US4216244A (en) * | 1978-09-19 | 1980-08-05 | Allen Alfred E Jr | Low sodium salt seasoning |
US4183965A (en) * | 1978-12-26 | 1980-01-15 | International Flavors & Fragrances Inc. | 2- and 3-Cyclotetradecen-1-ones as bitterness depressants |
US4219579A (en) * | 1979-01-25 | 1980-08-26 | Carl Piampiano | Means and method improving taste of saccharine sweetened food products |
US4642240A (en) * | 1982-09-30 | 1987-02-10 | General Foods Corporation | Foodstuffs containing 3-aminobenzesulfonic acid as a sweetener inhibitor |
US4871570A (en) * | 1983-03-22 | 1989-10-03 | General Foods Corp. | Foodstuffs containing hydrobenzene organic acids as sweetness modifying agents |
US4567053A (en) * | 1983-04-12 | 1986-01-28 | Tate & Lyle Public Limited Company | Method of inhibiting sweetness |
US4544565A (en) * | 1984-03-29 | 1985-10-01 | General Foods Corporation | Foodstuffs containing sweetness inhibiting agents |
GB2157148A (en) * | 1984-04-12 | 1985-10-23 | Tate & Lyle Plc | Method of modifying taste |
US4913921A (en) * | 1987-09-11 | 1990-04-03 | General Mills, Inc. | Food products containing fish oils stabilized with fructose |
US4910031A (en) * | 1988-12-19 | 1990-03-20 | Frito-Lay, Inc. | Topped savory snack foods |
US4994490A (en) * | 1989-04-03 | 1991-02-19 | The Nutrasweet Company | Novel N-(sulfomethyl)-N'-arylureas |
US4917913A (en) * | 1989-09-29 | 1990-04-17 | International Flavors & Fragrances Inc. | Use of sclareolide in augmenting or enhancing the organoleptic properties of foodstuffs |
US4988532A (en) * | 1989-09-29 | 1991-01-29 | International Flavors & Fragrances Inc. | Use of sclareolide to debitter a coffee beverage |
Non-Patent Citations (1)
Title |
---|
See also references of EP0661932A4 * |
Cited By (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995004476A1 (en) * | 1993-08-05 | 1995-02-16 | San-Ei Gen F.F.I., Inc. | Method of suppressing sweetness |
WO1995004479A1 (en) * | 1993-08-05 | 1995-02-16 | San-Ei Gen F.F.I., Inc. | Method of increasing pungency |
WO1995004477A1 (en) * | 1993-08-05 | 1995-02-16 | San-Ei Gen F.F.I., Inc. | Method of increasing sourness |
WO1995004478A1 (en) * | 1993-08-05 | 1995-02-16 | San-Ei Gen F.F.I., Inc. | Method of increasing bitterness and/or astringency |
US5766622A (en) * | 1996-08-14 | 1998-06-16 | The Procter & Gamble Company | Inhibiting undesirable taste in oral compositions |
US6461658B1 (en) | 1998-07-07 | 2002-10-08 | Mcneil-Ppc, Inc. | Method of improving sweetness delivery of sucralose |
US6998144B2 (en) | 1998-07-07 | 2006-02-14 | Mcneil-Ppc, Inc. | Method of improving sweetness delivery of sucralose |
WO2000001253A1 (en) * | 1998-07-07 | 2000-01-13 | Mcneil Specialty Products Company, Division Of Mcneil-Ppc, Inc. | Method of improving sweetness delivery of sucralose |
WO2000047045A1 (en) * | 1999-02-13 | 2000-08-17 | Zylepsis Limited | Preservative compounds and compositions |
JP2001233894A (en) * | 2000-02-21 | 2001-08-28 | Toyo Suisan Kaisha Ltd | Novel terpenoids and medicines utilizing the biological activity of these compounds |
JP4545868B2 (en) * | 2000-02-21 | 2010-09-15 | 東洋水産株式会社 | Novel terpenoids and pharmaceuticals utilizing their biological activity |
US7803982B2 (en) | 2001-04-20 | 2010-09-28 | The Mount Sinai School Of Medicine Of New York University | T1R3 transgenic animals, cells and related methods |
EP1706412A1 (en) * | 2003-12-30 | 2006-10-04 | SK Chemicals, Co., Ltd. | Novel pyridine derivatives, a process for their preparation and a pharmaceutical composition containing the same |
EP1706412A4 (en) * | 2003-12-30 | 2009-03-18 | Sk Chemicals Co Ltd | Novel pyridine derivatives, a process for their preparation and a pharmaceutical composition containing the same |
US9035085B2 (en) | 2004-05-14 | 2015-05-19 | Emisphere Technologies, Inc. | Aryl ketone compounds and compositions for delivering active agents |
US9512176B2 (en) | 2005-03-31 | 2016-12-06 | Centre National De La Recherche Scientifique | Age inhibitors |
FR2883873A1 (en) * | 2005-03-31 | 2006-10-06 | Pharmamens Sarl | AGE INHIBITORS |
WO2007055426A1 (en) | 2005-11-14 | 2007-05-18 | Kao Corporation | Liquid seasoning |
US8053014B2 (en) | 2005-11-14 | 2011-11-08 | Kao Corporation | Liquid seasoning |
US9101160B2 (en) | 2005-11-23 | 2015-08-11 | The Coca-Cola Company | Condiments with high-potency sweetener |
US8017168B2 (en) | 2006-11-02 | 2011-09-13 | The Coca-Cola Company | High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith |
US8399034B2 (en) | 2008-01-31 | 2013-03-19 | Kao Corporation | Miso |
JPWO2010113925A1 (en) * | 2009-03-30 | 2012-10-11 | 株式会社 資生堂 | UV damage reducing composition |
JP5727364B2 (en) * | 2009-03-30 | 2015-06-03 | 株式会社 資生堂 | UV damage reducing composition |
RU2535099C2 (en) * | 2009-09-29 | 2014-12-10 | Сисеидо Компани, Лтд. | Antioxidant composition |
US8962684B2 (en) | 2009-09-29 | 2015-02-24 | Shiseido Company, Ltd. | Antioxidant composition |
EP2353403A1 (en) | 2010-02-01 | 2011-08-10 | Symrise AG | Use of 1-(2,4-dihydroxy-phenyl)-3-(3-hydroxy-4-methoxy-phenyl)-propan-1-on |
US8992892B2 (en) | 2010-02-01 | 2015-03-31 | Symrise Ag | Use of 1-(2,4-dihydroxy-phenyl)-3-(3-hydroxy-4-methoxy-phenyl)-propan-1-one |
US9408407B2 (en) | 2010-04-15 | 2016-08-09 | Chromocell Corporation | Compounds, compositions, and methods for reducing or eliminating bitter taste |
US9872514B2 (en) | 2010-04-15 | 2018-01-23 | Chromocell Corporation | Compounds, compositions, and methods for reducing or eliminating bitter taste |
US9706790B2 (en) | 2011-10-20 | 2017-07-18 | Chromocell Corporation | Compounds, compositions, and methods for reducing or eliminating bitter taste |
CN103288673A (en) * | 2013-05-28 | 2013-09-11 | 广东药学院 | Platinum ligand and coordination compound thereof |
Also Published As
Publication number | Publication date |
---|---|
HU9401598D0 (en) | 1994-09-28 |
EP0661932A4 (en) | 1996-06-05 |
FI942463A0 (en) | 1994-05-26 |
BG98818A (en) | 1995-02-28 |
HUT68764A (en) | 1995-07-28 |
FI942463A (en) | 1994-07-26 |
SK62094A3 (en) | 1995-04-12 |
NO941972D0 (en) | 1994-05-26 |
CZ129094A3 (en) | 1995-12-13 |
NO941972L (en) | 1994-07-14 |
EP0661932A1 (en) | 1995-07-12 |
AU675778B2 (en) | 1997-02-20 |
CA2117284A1 (en) | 1993-06-10 |
JPH07504810A (en) | 1995-06-01 |
AU3225093A (en) | 1993-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU675778B2 (en) | Specific eatable taste modifiers | |
US5646122A (en) | Specific eatable taste modifiers | |
US6015792A (en) | Specific eatable taste modifiers | |
US6008250A (en) | Specific eatable taste modifiers | |
US5631038A (en) | Specific eatable taste modifiers | |
US5232735A (en) | Ingestibles containing substantially tasteless sweetness inhibitors as bitter taste reducers or substantially tasteless bitter inhibitors as sweet taste reducers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU BB BG BR CA CS FI HU JP KP KR LK MG MW NO PL RO RU SD US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) |
Free format text: CS |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2117284 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 62094 Country of ref document: SK Ref document number: PV1994-1290 Country of ref document: CZ Ref document number: 942463 Country of ref document: FI |
|
WWE | Wipo information: entry into national phase |
Ref document number: 94-00889 Country of ref document: RO |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1993900657 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 08244306 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 1995 461596 Country of ref document: US Date of ref document: 19950605 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 1993900657 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: PV1994-1290 Country of ref document: CZ |
|
WWR | Wipo information: refused in national office |
Ref document number: PV1994-1290 Country of ref document: CZ |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1993900657 Country of ref document: EP |